Page 1

Union for International Cancer Control | UICC

2018 Annual Report


Leading the global fight against cancer

“We unite and support the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda.”

01

Message from the President

3

02

Message from the CEO

4

03

Uniting the cancer community

5

Membership

6

Partnerships

8

9

Advocating for evidence-based policy solutions

Convening

12

World Cancer Day 12

World Cancer Leaders’ Summit 13

World Cancer Congress 14 04

Promoting greater equity

16

Capacity Building

17

UICC Resources and publications

24

05

Delivering a challenging and impactful agenda

26

Treatment for All

27

2018 UN High-level Meeting on NCDs

28

06

Working with our sister organisations

29

C/Can 2025: City Cancer Challenge

30

NCD Alliance

31

McCabe Centre for Law and Cancer

32

07

UICC Strategic review in 2018

33

An award-winning organisation

39

08 Financials

40

09

Board of Directors

43

The 2018-2020 Board of Directors

44

UICC Geneva team

45

10

Our members

46

11

Our partners

57

Partners’ support per programme

59


Message from the President It is with great pride that I write this introduction to the 2018 UICC Annual Report as the President of this wonderful organisation, UICC. Since my appointment in October last year at the World Cancer Congress in Kuala Lumpur, I have reached out to many of our members to understand the challenges they face in their own countries. Two things have become clear to me. Firstly, we are blessed to have so many amazing people and organisations in the UICC family who spend their lives improving cancer control in their countries, supporting patients, advocating for government support and encouraging fellow citizens to live healthier lives. Secondly, there is still so much that we all want to do to reduce cancer incidence and improve cancer treatment and care.

2018 UICC Annual Report

As I look back on 2018, I believe that UICC and its members have begun to mobilise action at a national level. After years of arguing cancer onto the global health and development agendas, I feel that our community is now demanding a response from governments to put in place robust cancer control plans that are well funded and executed with energy and enthusiasm, working closely with UICC members. Every day that passes we fail the most vulnerable in society, so we must take on the challenge of change with urgency. This is not beyond us as a community and I encourage all UICC members to continue to do the great work they do and reach out to UICC and other members to share learning and encouragement. In January 2019, only two years after it was launched, UICC’s City Cancer Challenge was established as a standalone entity, with an outstanding new Board of Directors led by Professor Sanchia Aranda and Dr Sue Henshall as the CEO. UICC will continue to work closely with the Foundation in the next three years as it continues to engage cities around the world to improve the quality and accessibility of cancer treatment in their populations.

My deep thanks to both Sanchia Aranda and Tezer Kutluk, both previous Presidents of UICC, who left the Board in October. They contributed immensely to the growth and standing of UICC in the cancer community and we will miss their presence at the UICC Board meetings. I would also like to acknowledge the new Board members, staff of UICC and Cary Adams, our CEO, who all worked with such enthusiasm in 2018 to deliver impressive impact. We are blessed to work with so many incredible individuals and institutions.

HRH Princess Dina Mired President Union for International Cancer Control

3


Message from the CEO In 2018, the UICC Board of Directors reflected on the achievements of the past few years and concluded a strategic review, which reconfirmed many of the ambitions from the last review in 2014 but set out some new challenges for the immediate future. The plans for the next few years are included in this Annual Report on pages 33 - 38. It is worth noting that we have committed to a new purpose statement, reflecting our desire to work more closely with the membership and to ensure that cancer continues to be a priority in the global health and development agenda. The reasoning for this subtle but important change is included on page 38. In 2018, we launched our Treatment for All initiative, which seeks to follow through on the commitments made in the World Health Assembly (WHA) cancer resolution from 2017, but as importantly, seeks to give UICC members the support they need to advocate more effectively for government action in their own countries. We demand four systemic changes in all countries: better registry data, more

2018 UICC Annual Report

comprehensive prevention and early detection, improved access to treatment and care, and to the highest quality palliative care. These are critical components of any national cancer control plan (NCCP) and we look forward to working with members in the coming years to make the aspiration a reality. UICC continues to grow steadily and impressively. The membership and partner bases are the largest they have ever been, and we are now seeing more organisations and companies interested in supporting our work. Financially, we run a sound organisation that covers costs and increases its ability to run meaningful programmes, which support all our members in all countries.

I would like to thank the Board, all the UICC staff, our members and the many partners who make the decisions and take on the workload to deliver the UICC’s objectives. As HRH Princess Dina says, we are blessed to work with so many inspirational people.

Dr Cary Adams Chief Executive Officer Union for International Cancer Control

We are indebted to the many volunteers who support our work, guiding and advising us on how we can make best use of our resources to deliver our activities.

4


Uniting the cancer community

2018 UICC Annual Report

5


Membership 2018 was a remarkable year for UICC membership. Our members led and actively participated in key activities, including World Cancer Day, the World Cancer Leaders’ Summit and the World Cancer Congress. UICC members took part in global advocacy initiatives, such as the call for elimination of cervical cancer, and more than 100 applications were received to become a Country Champion organisation under the Treatment for All initiative. Our members also benefited from the growing opportunities in our capacity building activities. Once again, our 1,117 member organisations were at the epicentre of all the work that UICC has done and we feel very proud of each and every one of the UICC family. Our time in Kuala Lumpur at the World Cancer Congress was filled with exclusive membership engagement activities and networking platforms, which contributed in building a strong sense of community. The Congress also featured the UICC Awards for UICC members for the first time, and, out of over 140 submissions, five outstanding ones were declared winners - see more on the next page. Members Regional Meetings highlighted and fostered collaboration between organisations to advance solutions and share best practices at regional level. These meetings were the highlight for members at the Congress, with a 50% increase in participation from the previous Congress, building the foundation for stronger regional engagement in 2019.

2018 UICC Annual Report

World Cancer Day was, once again, a platform for membership engagement, with more than 107,000 campaign materials downloaded from the website and used to increase impact. During 2018, there were a number of opportunities to convene the cancer community with a more regional focus. Events such as the International Cancer Conference of Tibet and The Economist Events’ War on Cancer Series in Jakarta, Dubai, and London were great examples of how we convene our community and maximise networking opportunities at events hosted by members and partners. Over 350 members attended the 2018 General Assembly and more than 160 voted for their representatives at the Board of Directors. A new Board took office under the leadership of HRH Princess Dina Mired of Jordan as UICC President and the newly elected Professor Anil D’Cruz as President-elect. HRH Princess Dina is a passionate advocate and her leadership will certainly be an inspiration for the global movement of organisations

“Being a part of the UICC community is confirmation that Run For a Cure Africa (RFCA) is part of the global fight against cancer. UICC has given us a platform to highlight the dynamic challenges we face as a breast cancer non-profit in a developing nation. UICC has helped RFCA build our capacity, strengthen our systems, and collaborate with other organisations to bring education and support to the patients whom we serve.” Ebele Mbanugo, Run For a Cure Africa (RFCA) UICC Member

2017 UICC SPARC grant awardee C3 Prize winner

working in cancer control.

73

new organisations joined UICC in 2018

6


2018 UICC Awards The UICC Awards were launched in 2018 and aim to identify and celebrate the exceptional contributions made by UICC members and inspire the cancer control community through their efforts. Open to UICC members only, nominations are sought during Congress years for the chance to be recognised for their initiatives. Winners were announced at an Award Ceremony during the World Cancer Congress in Kuala Lumpur.

CEO Award

Fundraising Award

Winner: Pat Garcia-Gonzalez, CEO, The Max Foundation, USA

Winner: Saving Lives One Bite at a Time, Restaurant Care Program, by King Hussein Cancer Foundation, Jordan

Finalists: Asem Mansour, CEO and Director General, King Hussein Cancer Center, Jordan; and Wondu Bekele Woldemariam, Executive Director, Mathiwos Wondu-YeEthiopia Cancer Society, Ethiopia

Finalists: Light a Candle, by Children's Cancer Center of Lebanon, Lebanon; and World's Biggest Coffee Morning, by Macmillan Cancer Support, UK

Advocacy with Impact Award

World Cancer Day Spirit Award

Winner: I Care for Palliative Care campaign, by Cancer Council New South Wales, Australia

Winner: Project PINK BLUE, Nigeria

Finalists: Tobacco Control programme, by Nepal Cancer Relief Society, Nepal; and #Sjekkdeg (Get Tested) campaign, by Norwegian Cancer Society, Norway

Judges’ commendation: Liga Portuguesa Contro o Cancro, Portugal Finalists: The Cyprus Anti-Cancer Society, Cyprus and Shwe Yaung Hnin Si Cancer Foundation, Myanmar

In 2018, UICC presence expanded to six new countries: Tajikistan, Brunei, Armenia, Sri Lanka, Timor Leste and Zimbabwe

There was a 50% increase in participation to the Members Regional Meetings at the World Cancer Congress

171

countries where there is at least one UICC member

Collaboration Award Winner: African Palliative Care Association’s collaborative initiative to support the implementation of national palliative care policies in Southern Africa (Swaziland, Mozambique and Zimbabwe) Finalists: Project ROSE (Removing Obstacles to cervical ScrEening), by University of Malaya, Malaysia; and World Cancer Research Day, by Asociación Española Contra el Cáncer, Spain

2018 UICC Annual Report

“UICC continues to provide vital linkage between advocacy, policy makers and the medical community. The several convening activities offer critical venues for dialogue, collaboration and cancer control planning. UICC is the glue that holds global oncology efforts together and keeps cancer on the radar screen for NCD groups.” Benjamin Anderson, Fred Hutchinson Cancer Research Center, UICC Member

7


Partnerships

Working in partnership is the only way to solve the complexity we face in the global fight against cancer. UICC has successfully delivered a challenging and impactful agenda to unite and support the global cancer community. We have also seen greater global commitment to fight cancer, including the WHA cancer resolution in 2017 and the 2018 Political Declaration on noncommunicable diseases (NCDs). It is now time to translate the commitments into action, scale-up our programmes, and accelerate progress on the ground. No single actor, public or private, can overcome the complexity of improving access to the cancer control continuum alone. This is why we continue to strengthen diverse partnerships for lasting, innovative impact. In 2018, we successfully worked with our 52 partners in the areas that we do best: Convening, Capacity Building and Advocacy. We deepened our partnerships with all sectors, including the private sector, leading cancer organisations, and foundations, building truly multisector partnerships.

2018 UICC Annual Report

“At Icon Group we are particularly proud to be working closely with UICC through our Vanguard partnership as it provides us with the unique opportunity to engage with key decision makers in cancer control, share our expertise and knowledge with 1,000+ UICC members globally, and advocate to integrate cancer control into the world health and development agenda.� Mark Middleton, CEO, Icon Group

8


Bringing the world together At the World Cancer Congress, which gathered about 3,000 delegates, more than 75 cancer organisations and companies contributed to delivering another successful event. Our members and partners organised 23 sponsored sessions, and Astellas held its third Oncology C3 Prize: Changing Cancer Care through innovative, non-treatment solutions. We also welcomed Diaceutics, Daiichi-Sankyo and Astellas as new World Cancer Day partners for the three-year campaign ‘I Am and I Will’.

Nurturing leaders to take national cancer control to the next level Building the leadership capacity of our members is crucial in translating global commitments into national actions. Thanks to our partners, such as Fondation Philanthropia, Prevent Cancer Foundation, Oman Cancer Association, MSD, and Roche, we are strengthening our Capacity Building programmes, including the regional ‘Leadership in Action’ meetings as part of the CEO Programme, as well as building the capacities of patient groups in low- and middle-income countries. Our commitments to work with CEOs of UICC membership organisations to enhance their skills and capabilities and our investment in Young Leaders is clear evidence that UICC is serious about building a community of leaders who will make change happen in all corners of the world.

“Partnering with UICC allowed me to fully understand how UICC operates and delivers impact globally. I am now confident that together we will be more impactful in reducing the global cancer burden and better achieving Tata Trusts’ ambition to deliver high quality, accessible and affordable care to cancer patients in India.” Professor Arnie Purushotham, Medical Director, Tata Trusts Cancer Care Program

“We’re proud to be a founding partner of the UICC CEO Programme, which builds the leadership capacity of cancer organisations across the globe and transforms their ability to address challenges in cancer control in their country.” Claire Mulhearn, Vice President, Global Communications, MSD

2018 UICC Annual Report

9


Advocating for evidence-based policy solutions Over 2018, UICC has continued to work with the cancer community to keep cancer on the global health and development agenda. The aim of these advocacy partnerships is to achieve the translation of global commitments into national action. Through UICC’s collaboration with members and partners, we have been able to develop and disseminate new evidence and tools to support cancer control advocacy. A few notable new resources produced were the global review of NCCPs with the International Cancer Control Partnership, the civil society call to action on cervical cancer elimination and the launch of the Global Cancer Commitments Navigator. None of this would be possible without the ongoing support of our advocacy partners, which include World Cancer Research Fund International, the Swiss Cancer League, the American Cancer Society and the National Cancer Institute USA. Delivering the ambitious agenda set out in Treatment for All and serving as a global voice for the cancer community requires committed and like-minded partners. Our work has reconfirmed the importance of long-term partnerships and a strong coordinated approach to improve cancer control globally.

2018 UICC Annual Report

Treatment for All: Driving national action from global cancer commitments Following the adoption of the cancer resolution ‘Cancer prevention and control in the context of an integrated approach’ at the 2017 WHA, UICC is excited to have launched the Treatment for All initiative. After a great initial year, we look forward to working with County Champions, Mentors and our Treatment for All partners on the implementation of the cancer resolution in countries around the world. Special thanks to our Treatment for All partners: American Cancer Society, Susan G. Komen, Swiss Cancer League and World Cancer Research Fund International.

10


UICC supports the World Health Organization-led Cervical Cancer Elimination Initiative The ambition to achieve a world free of cervical cancer The WHA in May 2018 saw UICC teamed up with WHO and other partners to launch a new call to action. In the same month, we saw the first financial commitments to cervical cancer elimination by PEPFAR and Unitaid, in recognition of the growing burden of cervical cancer. New GLOBOCAN data released in 2018 demonstrated the shocking scale of the issue. International Agency for Research on Cancer estimates suggest that 570,000 women are newly diagnosed with cervical cancer each year - equating to one woman every minute. 2018 also saw cervical cancer mortality exceed 300,000 deaths per year for the first time. This burden is disproportionately felt in the poorest countries and communities and underscores the disparity in access to effective, recommended prevention, early detection, treatment and palliative care interventions.

What has happened since the announcement of the Cervical Cancer Elimination Initiative? UICC members called for Head of State support of elimination at the United Nations General Assembly. His Excellency President Edgar Lungu, President of Zambia responded in New York City, sharing his personal commitment. UN system agencies and civil society organisations have rallied, quickly developing a global acceleration strategy supported by expert consultations, comprehensive modelling exercises, literature reviews and market shaping exercises for both the HPV vaccines and HPV DNA tests. A WHO Executive Board proposal and decision supporting the elimination goal and calling for consultation and rapid progression to a global strategy 2020-2030 was co-sponsored by 41 countries.

What can we expect in 2019? We urge UICC members and partners to get involved in strategy development: contributing to the WHO online consultation, which opened for input in March 2019; encouraging your governments to contribute to regional Member State consultations (April – July) and Regional Committee Meetings (September – November). In addition, we can anticipate publication of the modelling work, which underpins the elimination framework and new guidance from WHO on accelerating national action. Our advocacy story is clear, elimination is feasible in all countries. Our governments must add their own public commitments to the leadership shown by Australia, Zambia and Malaysia to scale up equitable access and impact of cervical cancer prevention and control, which will put all countries on the pathway to elimination.

“Cervical cancer is preventable and treatable. Each of the proven interventions are WHO best-buy recommendations. We know that elimination is feasible in all countries - so what are we waiting for? The global strategy on accelerating cervical cancer elimination will provide the 2030 framing we need to drive national scale up to high coverage and equitable access that will save lives today and continue to do so over the coming decades, transforming the lives of girls and women.” Professor Sanchia Aranda, UICC President 2016-2018 and CEO, Cancer Council Australia

2018 UICC Annual Report

11


Convening

World Cancer Day World Cancer Day 2018 marked the final year of the three-year ‘We can. I can.’ campaign. There was a sharpened focus in 2018 following the recent adoption of the 2017 cancer resolution coupled with the highly anticipated UN High-level Meeting on NCDs later in September. 2018 presented a real opportunity to harness this heightened global attention on both NCDs and cancer.

World Cancer Day also saw UICC members and partners actively taking part, with 76% of members participating in the global campaign. The final year of the ‘We can. I can’ campaign also featured a couple of outstanding collaborations that helped achieve greater and broader reach, including a partnership with global gaming giant, Electronic Arts’ FIFA Mobile, which reached close to two million video gamers.

The day achieved strong results: over three billion social media impressions, more than 460,000 tweets, nearly 1,000 activities in at least 130 countries, and over 90,000 visitors to worldcancerday.org. With a concerted media strategy pushing for in-depth, quality coverage, we witnessed a leap in the number of press articles, from 11,000 in the previous year to 14,000 in 2018.

‘We can. I can.’ was a test-pilot for a multi-year campaign, which allowed for longer-term messaging to drive more impactful action. Its resounding success has provided a sound foundation for the next three-year campaign. The new theme for the 2019-2021 campaign is ‘I Am and I Will’, which pairs the big issue of cancer with a personal commitment to action. The theme actively engages supporters by asking two questions: “Who are you?” and “What will you do?” to reduce the impact of cancer.

Governments around the world continued to engage on World Cancer Day, with 45 governments using the day to make formal statements and affirm their commitment on social media. Over 30 cities also joined on the day, illuminating emblematic and iconic landmarks in orange and blue in a show of support.

Looking ahead

Partners With special thanks to World Cancer Day campaign sponsors: Boehringer Ingelheim, Bristol-Myers Squibb, Merck, Movember, MSD, Amgen, Pfizer and Roche.

“Bristol-Myers Squibb remains a proud supporter of UICC and World Cancer Day. Collaborations like these are critical to raise awareness about how organisations and individuals can impact the global fight against cancer.” Amadou Diarra, BMS, Vice President, Global Policy, Advocacy & Government Affairs

The new 2019-2021 campaign theme

2018 UICC Annual Report

12


World Cancer Leaders’ Summit The 2018 World Cancer Leaders’ Summit took place in Kuala Lumpur in October in conjunction with the World Cancer Congress and gathered over 380 global leaders and influencers from 68 countries and 168 UICC member organisations. The Summit was hosted by the National Cancer Society of Malaysia and organised by UICC in partnership with the International Agency for Research on Cancer, the International Atomic Energy Agency and the World Health Organization. The event brought together a highly distinguished programme of speakers and participants to share inspiring examples of multi-stakeholder planning and action for ‘Cancer & Treatment for All’, aligned with UICC’s new advocacy initiative. Discussions explored how Treatment for All will support the full implementation of NCCPs to deliver strengthened health systems with strong links with other NCDs and health programmes and culminated in an urgent call to scale-up access to, and investment in, cancer services. In closing, HRH Princess Dina Mired called on governments, civil society, international organisations and private sector partners to invest in Treatment for All and what it aims to achieve: lives saved through equitable access to cancer services. She also called on the global cancer community to report on the advancements made at the next Summit, which will take place in Nur-Sultan, Kazakhstan, from 15 to 17 October 2019.

2018 UICC Annual Report

13


World Cancer Congress The 2018 World Cancer Congress took place 1-4 October for the first time in Southeast Asia under the title ‘Strengthen. Inspire. Deliver’. The National Cancer Society of Malaysia, supported by the Malaysian Ministry of Tourism and Culture and the Malaysian Convention and Exhibition Bureau, hosted the 25th edition of the Congress. Over 2,500 delegates from 120 countries (whom 41% were UICC members) gathered in Kuala Lumpur to listen to the advances made by many around the world in preventing and treating cancer. The Congress’ design facilitated discussion, debate, challenge and interaction. Delegates left inspired by the content and the sense of ambition and hope from world leaders in cancer control.

The main Congress programme was divided into five tracks, which included a new stream focusing on mobilising funds and attracting resources. In total, 330 international and multi-sectoral speakers presented in over 120 sessions. The sessions were deliberately diverse in structure and purpose. Hosting the Congress was an excellent opportunity for the National Cancer Society of Malaysia to advance its work in cancer control. Apart from uniting various national and regional stakeholders to drive national cancer agendas, the work leading to the Congress strengthened the Society’s collaboration with the government. Feedback from delegates was outstanding and we look forward to the next edition of the World Cancer Congress, which will take place on 19-22 October 2020 in Muscat, Oman.

95%

of delegates would recommend the Congress to a colleague

90%

of exhibitors rated the quality of interactions in the Global Village (exhibitors pavilion) as outstanding or very good

85%

of delegates rated their Congress experience from very good to outstanding Please visit worldcancercongress.org for more information

2018 UICC Annual Report

14


“Thanks to the World Cancer Congress, the Singapore Cancer Society has partnered with the National Cancer Center Singapore. This great partnership has allowed us to showcase our own local activities and expertise both at regional and global level. In addition, this event has been a wonderful learning and networking experience, including learning from the many experts in the various organisations doing their part in the fight against cancer.” Albert Ching, CEO at the Singapore Cancer Society, WCC Host Committee

“This is not a Congress, this is a movement.” Hon. Yuthar Al Rawahi, Founder and Life President, Oman Cancer Association

2018 UICC Annual Report

15


Promoting greater equity

2018 UICC Annual Report

16


Capacity Building

Building on the successes of previous years, 2018 has seen the further growth, development and establishment of UICC’s Capacity Building activities, in line with its mission to support the cancer community. Alongside the core programmes of fellowships, grants, CEO Programme, Young Leaders and Master Courses, new initiatives have been developed, including an emphasis on building capacity for advocacy, and exploring opportunities to engage more effectively at the regional level.

CEO Programme In 2018, UICC’s tailored offer to CEOs or senior executives of member organisations focused its activities on the World Cancer Congress. Three exclusive sessions, a networking event and CEO-track within the main Congress programme attracted participation from 105 CEOs across 53 countries, providing them with meaningful opportunities to share knowledge, create new ideas and provide peer support. 2018 saw also the introduction of a CEO Award, part of the inaugural UICC Awards for UICC members. Culminating in a lively ceremony during the World Cancer Congress, already in its first year the CEO Award attracted an impressive range of entries and promises to become a key platform to celebrate good practice in leadership and management for years to come. In 2019, UICC, in conjunction with its members, will be hosting a series of ‘Leadership in Action’ meetings for senior executives at the regional level to discuss common challenges and opportunities, share best practices within their regional context and help build regional networks for change.

2018 UICC Annual Report

“The most valuable part of the CEO Programme is the networking. Just the fact that you are bringing the CEOs together under different themes is important.” Ulrika Årehed Kågström, Secretary-General, Swedish Cancer Society/Cancerfonden, Sweden

240+ senior executives engaged in the CEO Programme since its launch in 2016

17


Young Leaders Programme

Seven Young Leaders graduated from the Young Leaders’ Programme in 2018 at the World Cancer Congress, having completed the first programme in its revised 12-month format, which launched at the 2017 World Cancer Leaders’ Summit in Mexico City, Mexico. In 2018, the Young Leaders had the opportunity to participate in relevant conferences or to pursue a study visit, with the aim of furthering regional impact and supporting the establishment of new collaborations. At the 2018 World Cancer Congress, the Young Leaders played an active role, in particular, delivering two sessions exploring themes of global leadership and local impact, and how best to nurture Young Leaders to help achieve the cancer-related Sustainable Development Goals (SDGs) targets. The alumni community is a vibrant, engaged and supportive network of individuals committed to advancing global cancer control, and now includes 36 Young Leaders from 19 countries. As their individual careers progress, it is exciting to reflect and observe the role the programme has played; with evidence of broadened horizons, from local to national, national to regional or global; and new professional opportunities, projects, collaborations or funding. UICC looks forward to continuing to work with this community, building on their insights to further develop the programme for future years.

2018 UICC Annual Report

“Being part of the Young Leaders Programme has been a life-changing experience. Being a clinician, the programme helped broaden my perspective thanks to the various people I met through UICC’s network. I am not the same doctor that I was in 2017 before starting the programme. It has given me a macroscopic view of the cancer control arena and made me think of the impact I can make beyond the patients I see.” Supriya Jayant Sastri, Tata Memorial Hospital, India. Young Leader 2017-2018

36

Young Leaders from 19 countries in the alumni community

18


UICC Fellowships

It was another strong year for the UICC Fellowships programmes, with a total of 158 applications received and 73 cancer professionals and health workers from around the world given the opportunity to visit a worldclass mentor in their field and develop important new skills and knowledge in all aspects of cancer control. Together, the Technical Fellowships programme and its sub-programme dedicated to Francophone Africa, Bourses pour l’Afrique Francophone, awarded 53 one-month fellowships. The YY study grant programme allowed five established cancer investigators to participate in three-month collaborative visits to further cancer research, while the African Cancer Fellowship programme provided 15 cancer professionals the opportunity to participate in a dedicated Master Course and workshop on cancer care delivery in Africa at the World Cancer Congress, in addition to a one-month fellowship visit. Over 90% of Fellows surveyed one year after their return home are still in touch with their host supervisors, fostering the formation of networks and long-term international collaborations, and highlighting the long-term impact of the programme.

73 “I am a strong advocate for sharing practices. We don’t all need to go through trial and error or reinvent the wheel. However, it is important to adapt the knowledge acquired to the realities of our low resources settings for our skills to be useful.” Sokhna Ndiaye, Fellow and host, Centre Hospitalier Universitaire Aristide Le Dantec, Senegal

fellowships awarded to support individuals to develop new skills and knowledge

60

institutions from 24 countries shared their expertise by hosting fellows

4,000+

fellowships awarded in the last 50 years

2018 UICC Annual Report

19


Education and training opportunities

Over 200 registered delegates to the World Cancer Congress followed one of the six three-month online Master Courses, which ended with a full-day workshop in Kuala Lumpur. The six courses offered included topics on cancer awareness and prevention, strengthening patient groups, using law in cancer control, effective cross sector partnerships, cancer care delivery in Africa and metastatic breast cancer, with two of these further building the capacity specifically of our SPARC awardees and the African Cancer Fellows, one of our fellowship programmes. 100% of respondents to the post-course survey indicated that they would recommend Master Courses to colleagues, with over 80% agreeing that learning from the course will improve the ways they undertake their daily work.

“The course has given me the opportunity to expand my network with other professionals, not only in my region but also with other parts of the world. The time I spent in the Master Course to learn, share and exchange knowledge was worth every minute.� Thao Tang Thi Thanh, Program Coordinator, The Max Foundation, Vietnam

More than 200 World Cancer Congress delegates participated in a Master Course

2018 UICC Annual Report

20


Organisational

Building capacity in advocacy:

grants

National activation of Treatment for All

SPARC Metastatic Breast Cancer Challenge: Seeding progress and resources for the cancer community to address unmet needs of metastatic breast cancer patients worldwide. Since 2015, in partnership with Pfizer, 40 grants have been awarded to cancer organisations addressing important gaps for metastatic breast cancer across 30 different countries. Through the SPARC programme, organisations have received a package of seed-funding, capacity building and convening opportunities to launch and strengthen new projects. Since the initiative launched, over 14,000 people have been reached directly through SPARC projects and more than 141,000 people have benefitted from SPARC advocacy campaigns and information materials. Successes include the creation of an online application to support patients in Canada and in India, the launch of the first patient navigation programmes in Nigeria and Trinidad & Tobago, and the contribution to the development of supportive national legislation on cancer in Brazil. In 2018, three SPARC grantees received international prizes or awards for their efforts in cancer control.

2018 UICC Annual Report

On World Cancer Day 2018, UICC launched its Treatment for All advocacy campaign to call for implementation of the provisions of the 2017 WHA cancer resolution. In order to support UICC members to engage at a national level and advocate for the translation of these global commitments into national action, UICC began working with three organisations to shape a programme of work to build advocacy capacity within UICC’s membership. Three Country Champions, Indonesian Cancer Foundation, Indonesia; Salvati A.C., Mexico; and Uganda Cancer Society, Uganda, were supported to develop a national Treatment for All advocacy campaign through in-country visits, an expert-led workshop in conjunction with the 71st WHA, and remote guidance. The efforts of these three organisations is showcased in three Treatment for All films launched at the 2018 World Cancer Leaders’ Summit. The learning from 2018 is informing the development of a Treatment for All toolkit and online course, to be released in 2019.

“What we want to say to all countries is, if we all work together towards the same goal, we will work more efficiently and have better outcomes.” Isabelle Aloi-Timeus, Founder, Salvati A.C., Mexico Treatment for All Country Champion 2018

In October 2018, UICC also announced its call for expressions of interest for further organisations to become a Treatment for All Country Champion and Mentor, with the intent to scale-up support to 20 organisations. More than 100 applications from over 50 countries were received, and new organisations were announced on World Cancer Day 2019.

21


Engaging regionally

UICC continues to develop its engagement at a regional level, adapting activities to ensure they are relevant, responsive and address the needs of our members across the regions; increasing access to opportunities through overcoming language or other barriers; and developing new initiatives based on regional needs. UICC successfully implemented a number of initiatives in specific regions: Leadership Development Grants in Latin America offering senior executives the opportunity to learn from another, Bourses pour l’Afrique Francophone that has notably increased the number and quality of applications from this region, and the launch of a Patient Groups Programme in the Asia Pacific region to explore how UICC can better support these types of organisations. The learning from these initiative will be taken forward to support other regions in the coming years. A particular highlight in 2018 was the six Regional Meetings at the World Cancer Congress, which gathered over 350 participants to foster and celebrate collaborations amongst UICC members.

2018 UICC Annual Report

“This programme is a wonderful step in the right direction to aggregate knowledge and resources in the region. And it is successful in generating significant energy among the community.� Gautami Tadimalla, Life Again Foundation Patient Group Programme participant

22


Spotlight on a Capacity Building journey

Paul Ebusu, Executive Director of Uganda Cancer Society (UCS), was selected to be a UICC Young Leader in 2017-18. As a member of the National Steering Committee of the Uganda National Cancer Control Program, as well as the Uganda Technical Working Group on NCDs and Cancer Diagnostics, Paul represents the interests of Ugandan civil society in the country’s cancer control planning efforts. His ambition in applying to be part of UICC’s Young Leaders’ programme was to strengthen his leadership skills and increase the visibility of his organisation, particularly its capacity to work through partnerships. Thanks to the programme, he was able to visit Kenya in August 2018 to benchmark processes that led to Kenya’s successful development of their National Cancer Control Plan (NCCP) and to understand the role played by civil society in the process.

2018 UICC Annual Report

During his presence at the 2017 World Cancer Leaders’ Summit as a Young Leader, he was also able to strengthen connections that supported his organisation’s selection as one of the first Treatment for All Country Champions. Building on the knowledge he learned through his country visit to Kenya, and supported by UICC through the national activation workstream of Treatment for All, Uganda Cancer Society launched its national Treatment for All advocacy campaign on World Cancer Day, 2019, focused on drafting and implementing a National Cancer Control Plan by February 2020.

Paul acknowledged: “One of the primary benefits I received through UICC was the international exposure it offered me. The opportunities for increased engagement at the regional level with UICC’s networks as well as the alignment with the Treatment for All global campaign helped me and my organisation to contribute more effectively towards a ‘cancer free Uganda’.”

23


UICC Resources and publications International Cancer Control Partnership (ICCP)

to researchers to civil society, to advocate for NCCPs that are effectively formulated, financed, implemented and monitored.

Since 2012, the International Cancer Control Partnership has brought together over twenty organisations to coordinate activities and resources to enhance global cancer control.

There were strengths and limitations across the reviewed NCCPs. Greater attention was placed on prevention and early detection compared to cancer treatment (30% less). Overall, countries had strong inclusion of early detection in their plans with stronger emphasis on cancer screening than other interventions that promote early diagnosis. The delivery of cancer services and the health workforce were poorly addressed (50% less, compared to prevention) across the plans.

In 2018, the ICCP, with project leadership from WHO and UICC, conducted a global review of NCCPs and other cancer-related documents. The analysis, whose findings have been published in the Lancet Oncology, showed the importance of NCCPs in providing strategic direction to NCCPs and to reducing the cancer burden. As part of this international collaboration, a group of 67 expert reviewers based in 16 different countries reviewed over 500 documents from 158 countries. The survey consisted of a 121-question tool covering the cancer control continuum. The purpose of the review was to understand the strengths and limitations of current plans and the key domains addressed. Data from the review can be used by all stakeholders, from national planners

Access the portal here iccp-portal.org

2018 UICC Annual Report

Strengths

Remaining Challenges

“We are very excited to provide the first global review of cancer-related national health plans, which serves as a starting point to monitor the evolution of NCCPs globally and assess their impact. We have seen a significant increase in the number of NCCPs over the past 15 years, now we need to see an improvement in their content and implementation.� Dr Sonali Johnson, Head of Knowledge, Advocacy and Policy, UICC

Treatment

Prevention Service Delivery

Health Workforce Early detection

24


TNM

International Journal of Cancer (IJC)

For over 50 years, UICC has managed the TNM Classification of Malignant Tumours, the most widely used system to classify the anatomical extent of cancer.

An official publication of UICC, the International Journal of Cancer concentrates on fundamental studies that improve understanding of the mechanisms of cancer and shed light on effective diagnostic tools and treatments. In 2018, IJC’s impact factor increased from 6.513 to 7.360 and the journal is ranked 23rd out of over 200 oncology journals by the ISI Journal Citation Report, demonstrating the IJC’s standing as a leading journal in the field of oncology.

In 2018, in collaboration with National Cancer Institute USA, Center for Disease Control and the Lancet Oncology, the UICC TNM Project convened international experts for a Global Consultation on Prognosis and Patient Outcomes in Cancer to review the current understanding of prognostic classifications in cancer and to discuss them in the context of cancer control and

Journal of Global Oncology (JGO) The Journal of Global Oncology, launched in partnership with the American Society of Clinical Oncology (ASCO) in 2015, is an open-access journal that provides a platform for sharing innovation, best practice and programmatic success in cancer control in resource-limited settings. All accepted abstracts from the World Cancer Congress have been published online as a supplement in JGO.

2018 UICC Annual Report

Journal Impact Factor

value-based care.

9 7.36

7.5 6

6.531 5.007

5.085

2013

2014

5.53

4.5 3 1.5

2015

2016

2017

JCR Years

25


Delivering a challenging and impactful global agenda

2018 UICC Annual Report

26


Treatment for All Treatment for All helped to shape and guide UICC’s global advocacy work throughout 2018. January saw the launch of the ‘Global Cancer Commitments Navigator’ a tool that helps identify the linkages between key global cancer control documents and the Treatment for All pillars to support strong global advocacy messages.

Treatment for All

Using Treatment for All, UICC developed key messages to drive advocacy around the 2018 High-level Meeting on NCDs, as well as using them as a framework for statements at the WHA. The Treatment for All messages resonated well in conversation with Permanent Missions in Geneva, UICC members and key partners, who recognise that data, early detection, timely treatment and palliative care not only provide a foundation for comprehensive cancer care, but also support strong and resilient health systems that could benefit all patients.

“We know Treatment for All is possible in every country. What we need is strategic and funded national plans and passionate leadership to ensure that quality cancer care is more widely available to all.” HRH Princess Dina Mired, President, UICC

2018 UICC Annual Report

27


2018 UN High-level Meeting on NCDs

2018 has been a landmark year for the global cancer and NCD community as, on 27 September, political leaders from around the world came together at the third United Nations High-level Meeting on NCDs to review progress and set out a route to reinvigorate action to achieve the global NCD targets for 2025 and 2030.

At the September meeting, HRH Princess Dina delivered a rousing speech calling on the assembled Heads of State to accelerate action on behalf of all civil society organisations. She emphasised that the global community has the information, tools and skills needed, but that action had been limited by political inertia, which was continuing to cost people their health and wellbeing.

Recognising that preparations for these meetings are as important as the documents they produce, UICC worked with the Can25 group to mobilise cancer advocates. A specific working group was established to share intelligence and connect advocacy taking place nationally to conversations being held in Geneva and New York. We collaborated with the NCD Alliance to establish common advocacy priorities and coordinate briefings for the Permanent Missions in New York and Geneva.

Looking ahead to 2025 and beyond, the political declaration falls short of the ambitions set out by UICC and the NCD Alliance, but it does contain key language that supports cancer control, including a specific paragraph calling on countries to “promote access to affordability diagnostic, screening, treatment and care |as well as vaccines that lower the risk for cancer...�. UICC will be taking this challenge up in our work in 2019. Read an assessment of the 2018 Political Declaration on NCDs here.

2018 UICC Annual Report

28


Working with our sister organisations

2018 UICC Annual Report

29


C/Can 2025: City Cancer Challenge

UICC’s City Cancer Challenge initiative was launched at the 2017 World Economic Forum Annual Meeting in Davos as a coordinated response to the urgent need to support resource-limited countries in reducing their growing cancer burden. Since then, the initiative has continued to accelerate efforts to deliver sustainable, quality cancer care solutions in cities, engaging over 80 health facilities, 800 healthcare professionals, 650 patients and 50 partners in its first four cities – Asuncion, Cali, Kumasi and Yangon. In 2018, City Cancer Challenge took another step towards achieving its mission of creating a global community of cities, with Kigali, Porto Alegre and Tbilisi joining the Challenge.

Building on the early successes in first cities, such as the adoption of a new cancer law in Paraguay, in 2019 City Cancer Challenge will be working to create new opportunities to share lessons learned across its community, and to advance sustainable financing for cancer to support cities as they implement local solutions. 2019 will also mark the transition of C/Can to a standalone Swiss foundation, welcoming a new Board of Directors as of January 2019. This transition is supported by a Memorandum of Understanding with UICC, laying the foundations for continued collaboration and exchange.

citycancerchallenge.org

2018 UICC Annual Report

“Consensus building between the private and public sectors is required to make lasting progress. Paraguay should use City Cancer Challenge as a laboratory to then drive health system reform.” Santiago Pena, former Minister of Finance of Paraguay

“Through City Cancer Challenge, the city of Kigali has the opportunity to deliver a more effective cancer treatment solution by leveraging existing infrastructure at different levels of the healthcare system in the city.” Patricia Muhongerwa, Vice Mayor in Charge of Social Affairs, City of Kigali

30


NCD Alliance

The NCD Alliance (NCDA) continued its core functions of global advocacy, accountability, capacity development, and knowledge exchange throughout 2018. The third United Nations High-level Meeting on NCDs in September 2018 was a milestone in the global NCD response, and the first time NCDs were reviewed in the SDGs era. NCDA led civil society engagement throughout the process, ensuring comprehensive inputs to the outcome document that presented a balanced approach to prevention, treatment and care, and addressed risk factors for NCDs. This effort resulted in civil society and people living with NCDs being recognised in the final outcome document as key partners in the NCD response. To reinforce UN High-level Meeting advocacy, and tapping into collective frustrations with apathy and inaction, NCDA launched its first thematic campaign, ENOUGH. The NCD movement was mobilised with a digital campaign and the first Global Week for Action on NCDs, reaching millions of people in dozens of countries. People living with NCDs, high level champions

2018 UICC Annual Report

and hundreds of advocates from NCDA’s network of supporters, members and over 55 national and regional alliances demanded “our health, our right, right now.” 2018 also saw the launch of the NCD Countdown 2030 initiative, a mechanism for independent accountability to help countries accelerate progress on NCD commitments. This work is strengthened through the voices and perspectives of people living with NCDs, which has grown in prominence since the establishment of the Our Views, Our Voices initiative. Finally, NCDA’s membership structure opened, and the Alliance has continued to expand and grow its network of partners and members since it became a standalone non-governmental organisation in May 2017.

ncdalliance.org

31


McCabe Centre for Law and Cancer

With the launch of their 2018-2022 strategic plan in February, the McCabe Centre for Law and Cancer has continued to strengthen its focus and impact in advancing law to fight cancer and other NCDs. The McCabe Centre’s reputation as the only centre of its kind promoting law as an effective tool in the prevention and control of cancer, and other NCDs, was further amplified with their designation as a WHO Collaborating Centre. Through the collaboration, the McCabe Centre will continue to support development outcomes by building the capacity of low- and middleincome countries to implement legal interventions that reduce exposure to NCD risk factors; and improve laws to advance equitable healthcare for all. With tobacco use still the single greatest avoidable risk factor for cancer deaths, the McCabe Centre celebrated the news of Australia’s third resounding victory in the defence of its tobacco plain packaging laws with the World Trade Organization (WTO) decision. Since the announcement, the McCabe Centre has run three workshops on the WTO decision to support countries progressing such laws, maintaining the global momentum towards plain packaging.

In 2018, the McCabe Centre continued to share knowledge and build the capacity of lawyers and policymakers with several programs throughout the year, training over 60 participants from 38 countries. In collaboration with the WHO Regional Office for the Western Pacific, the McCabe Centre also led a UICC Master Course: Using the law and policymaking to promote cancer prevention and control, successfully tailoring and delivering legal training to cancer control practitioners.

mccabecentre.org

Image Credit: © Room3/McCabe Centre

2018 UICC Annual Report

32


UICC Strategic review in 2018

2018 UICC Annual Report

33


Every four years the Board of UICC reviews the long-term strategy of the organisation. The last review took place in 2014, so, in 2018, under the leadership of our President, Sanchia Aranda, the Board conducted a comprehensive review of UICC’s strategy.

The Board conducted the 2018 UICC Strategy Review with an open mind, prepared to challenge the thinking of four years ago on the basis that UICC had developed and changed, and the environment in which it operates had also evolved during this time. For example: 1. 1

The SDGs were not in place in 2014 when the strategy was last reviewed.

2 2.

UICC had not envisaged its role in driving action at city level in 2014, but this became a large part of its activities in 2018.

3. 3

UICC’s membership has grown and changed over the last four years and, therefore, as a membership organisation, we should ensure that we still properly reflect the views of that base.

4. 4

UICC has become a leading advocate of multisectoral action and has led the way through its City Cancer Challenge 2025 initiative, which has successfully engaged UN agencies, governments (national and city), civil society, the private sector and international organisations to help cities improve cancer treatment and care for their communities.

The strategic review process uncovered key headline views from our stakeholders on the role UICC should play in the global health community and what our priorities should be through to 2030.

2018 UICC Annual Report

34


Strategic review Membership feedback 265 membership organisations completed a strategy questionnaire in the second-half of 2017. UICC’s membership outlined two key roles requiring attention in the coming years. • Global advocacy to promote cancer control in the global health and sustainable development agendas (61%) • Capacity building initiatives for member organisations and its future leaders (40%) In addition, members expressed a desire for UICC to develop a regional approach that recognises the nuances in cancer profile, preparedness and capacity to respond to a set of unique cancer challenges in each region. Partnerships and the undoubted ability of UICC to work with different organisations were considered to be important roles in the future, with assistance being provided to members to help them implement change in their own countries. Three priorities were highlighted as areas in which UICC could play a more prominent role in the next decade: • Improvement in the access to high-cost treatment commodities around the world (recognising that cost is relative to each country’s GDP/health spend situation),

External stakeholders, partners and international global health leaders 17 in-depth interviews with UICC global stakeholders were conducted and an online survey was completed by 71 individuals who have worked with UICC on a number of different initiatives. The external stakeholders applauded UICC’s role in delivering the three pillars of its work (convening, capacity building and advocacy), engaging a broad range of stakeholders and partners, representing a diverse membership base and providing increased focus on the needs of cancer patients in low- and middle-income countries. External stakeholders consider that UICC should play a role in tackling the global equity gap and unifying a fragmented cancer advocacy agenda. They urged UICC to focus on improving the capacity of UICC members to be more effective in their countries and to deliver this with consideration for regional specificities.

The UICC Board of Directors recognises that much of what UICC does today is endorsed by members, partners and external stakeholders and UICC is encouraged to continue the great work it does as it sets out an ambitious new agenda through to 2030. This means that we shall continue to drive global impact through our current portfolio of work with a continued focus on convening with excellence, advocacy with impact and helping UICC members strengthen their capacities over time. However, four new areas of focus have emerged through the strategy review, which will become embedded in the philosophy and work of the organisation going forward: 1. 1

Increased regional focus

2. 2

Addressing gaps through innovative partnerships

3. 3

Capacity building with impact

4. 4

Greater depth of relationships

UICC’s role as a trusted partner is applauded and UICC is encouraged to invest more into fostering this role in the future. UICC is also encouraged to reach out to other players with influence in the global areas of environment, communicable diseases, women’s health and regional health organisations.

• closing the gaps in overall funding for cancer control and • increasing our drive for increased tobacco control.

2018 UICC Annual Report

35


Increased regional focus

• We will extend our membership base in all regions, encouraging members to participate actively in our flagship activities, making best use of World Cancer Day and participating in our capacity building work as deliverers of training and education and not simply as recipients.

• As we have shown in the past with our leadership in cocreating the NCD Alliance, the McCabe Centre for Law and Cancer and the City Cancer Challenge Foundation, we are able to mobilise action and engagement in addressing significant gaps in the global health community.

• We will work with our membership to define changes in our operating model, allowing us to deliver support and services that are regionally sensitive whilst enhancing our role as a global convenor and advocate for the cancer community.

• We will identify future global leaders in cancer control and harness their enthusiasm and talent through a growing young leader community that receives outstanding support and training.

• We will embrace new technologies to ensure that the membership of UICC is fully integrated over time, with a platform that encourages dialogues across the many thousands of individuals who work in the organisations we count as members.

• We will extend our reach and impact through more regional events, taking our World Cancer Leaders’ Summit and Congress to different regions and ensuring that they properly reflect the priorities of the region and leave a lasting impact that enables the local community of cancer organisations to follow through with their national governments.

Addressing gaps through innovative partnerships

UICC should continue to extend its membership base at organisational and individual level, refining its operating model so that it can respond to regional differences around the world.

• We will develop an operating model that embraces new technology to connect our members across regions, enabling them to learn from each other more efficiently than today. • We will encourage more dynamic intra-regional engagement and the sharing of best practice with increased peer-to-peer learning.

2018 UICC Annual Report

UICC should expand the range of stakeholders who are invested and engaged in global cancer control. We should also strategically assess where there are critical gaps in the cancer agenda, and then identify potential partnerships to fill those gaps. UICC will play a critical role as a catalyst, an incubator and a coordinator – facilitating innovative and effective partnerships that benefit member organisations and contribute to advancing the global cancer agenda.

• We will demonstrate through action the possibility of working with the private sector to advance cancer control and create greater global equity without compromising our independence and ability to work with and represent the cancer community. • We will continue to encourage partners to work together in and across industries to forge new powerful alliances, which collectively can address a global issue that none can address alone.

• We will remain flexible in our approach so that, as opportunities arrive to partner with like-minded organisations on a topic of great mutual benefit, we can help to accelerate the progress of the initiative, designing programmes that truly have global impact.

36


Capacity building with impact

Greater depth of relationships

UICC will extend its capacity building activities and seek to measure the impact of these initiatives going forward, to better understand the value and long-term influence of each programme. Secondly, UICC will focus on capacity building activities where the benefits clearly extend beyond just a handful of individuals and should leverage technology and our network to expand the reach of our capacity building efforts, where possible.

UICC must deepen its engagement with its members - both in terms of mapping and leveraging the diverse expertise available among the membership organisations, as well as in providing more meaningful engagement. UICC will utilise technologies more effectively to facilitate regional membership platforms or hubs. We will engage with all those involved in our members’ organisations, extending beyond a few individuals in each organisation.

• We will create a fully interactive cancer community that has the ability to work with each other seamlessly, with UICC being the catalyst for a new, dynamic online platform. We will connect all staff of all member organisations interactively so that we can share best practice, provide peer-to-peer support and extend from an organisational member model to an individual one.

• We will develop a new, innovative electronic platform that will connect all UICC members and their staff so that the reach of UICC extends beyond 1,070 organisations to tens of thousands of individuals.

• We will dramatically extend our suite of capacity building services and products to touch far more UICC members and their staff in regionally sensitive ways. • We will ensure that all UICC members have the skillsets to work with their governments to contribute positively to the development and implementation of their NCCPs, positioning the ambition in the context of the SDGs. • We will bring to our membership base an increasing portfolio of partners who are willing to train and develop their capabilities. • We will work with our community to measure cancer control impact and improvements country by country.

2018 UICC Annual Report

• We will refine our operating model so that we have greater insight on the needs of each region to improve the services and products we deliver to all.

In defining UICC’s long-term role in the cancer arena, it is clear that UICC remains the global voice in cancer control, linking global stakeholders and agendas with the voices of impacted nations and communities and connecting global commitments. We need to leverage a collective voice to urge for more global engagement on cancer, mobilising the solutions and partnerships that will tackle the growing cancer burden in all countries. UICC effectively catalyses and convenes partners, champions and organisations – we must harness this skill to amplify impact and fill critical gaps in cancer control. Increasing equity - equitable access to information, human and financial resources, affordable medicines and innovations - is foundational to UICC’s vision for 2030.

• We will listen to our membership as they work with governments to implement the SDGs, in order to adjust the support we deliver to them. • We will encourage members to become more active in helping other organisations address known skill gaps or educational needs, so that we become a more united and supportive organisation. We recognise that there are extraordinary capabilities, knowledge and experience in our membership and we will strive to help all to share these great resources with others. • We will help those organisations facing the greatest challenges by galvanising support from across the UICC membership.

37


A refreshed purpose statement reflecting our renewed ambitions Since 2014, UICC’s purpose statement has been: “We unite the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.� This 2018 strategic review caused the Board of Directors to reflect on the purpose statement of UICC. It is now appropriate to change it given that much of the work to place cancer on the global health and development agenda has been completed. With effect from January 2019, the new purpose statement of UICC is:

We unite and support the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda. This new purpose statement properly reflects our ambitions through to 2030 as set out above.

2018 UICC Annual Report

38


An award-winning organisation Over the last four years, UICC has been recognised for its efforts in various initiatives in collaboration with its members, partners and the cancer community across the globe. We are very proud of our achievements and for these to be recognised internationally is of great pride to the Board and the UICC team.

International Congress and Convention Association (ICCA) Incredible Impact Award for the impact following the 2017 World Cancer Leaders’ Summit in Mexico City

UICC’s CEO, Cary Adams, awarded ‘Chief Executive of the Year’ at the International and European Association Awards 2015

‘Best Website and Integration’ at the International & European Association Awards 2018

‘Best Membership Engagement’ Award at the International & European Association Awards 2017

‘Best Association Website’ at the European Association Awards 2018

‘Best use of Social Media’ at the Association Excellence Award 2017 for the 2016 World Cancer Congress campaign

2018 UICC Annual Report

‘Best Conference Development Award’ at the International & European Association Awards 2016

‘Most Successful NGO in the Health Sector for the Year 2016’ by the Society for Health Volunteers in Turkey

39


Financials

2018 UICC Annual Report

We finish the year with a growing organisation and a set of financial results that reflect UICC’s continued diligence in the way that we run our financial affairs. The 2018 financial results were audited by PWC in April 2019. Our results demonstrate balanced books, receiving enough income to cover all costs of operations. Our reserve levels remain at three months of operating costs and we have sufficient carry over funds to kick start great work in Capacity Building and Advocacy.

Importantly, through careful management of the City Cancer Challenge initiative, we are able to launch the initiative in January 2019 as a standalone Foundation with sufficient funds for it to operate effectively in 2019 and beyond. The move of City Cancer Challenge will impact the balance sheet and income levels of UICC in 2019, but we have robust plans to grow the funding levels through a refreshed strategy that will be rolled out in the year.

40


These figures, as presented, represent a summary of the financial statements of UICC. A complete set of the audited financial statements for 2018, including accompanying notes, may be obtained upon request at taylor@uicc.org.

Balance sheet at 31 December 2018 in US Dollars

ASSETS

2018

2017

Current accounts

4,535,458

5,436,512

Deposits & short term investments

2,679,613

4,449,661

377,878

222,524

Other receivables Prepaid expenses

31,639

698,895

7,624,588

10,807,592

Fixed assets, net

368,636

456,613

TOTAL NON-CURRENT ASSETS

368,636

456,613

7,993,224

11,264,205

TOTAL CURRENT ASSETS

TOTAL

LIABILITIES

2018

2017

Accounts payable

201,425

244,704

Accrued expenses

137,792

245,054

Deferred income

678,380

1,497,294

168,224

215,710

TOTAL CURRENT LIABILITIES

Other liabilities

1,185,821

2,202,761

Trust funds - restricted for activities

4,321,815

6,589,214

Fund balance - unrestricted

2,485,588

2,472,229

TOTAL FUND BALANCES

6,807,403

9,061,444

TOTAL

7,993,224

11,264,205

2018 UICC Annual Report

2018 Income and expenditure

38% Convening, Capacity building, Advocacy and other initiatives

2018 INCOME

2018 EXPENDITURE

21%

World Cancer Congresses

22%

Members & Partners

7%

Publications

12%

Other

45% Convening, Capacity building, Advocacy and other initiatives 21%

World Cancer Congresses

34%

Operating Costs

41


Income and expenditure at 31 December 2018 in US Dollars 2018 UNRESTRICTED

2017

RESTRICTED

TOTAL

UNRESTRICTED

RESTRICTED

TOTAL

INCOME Membership Dues and Contributions

1,279,861

1,279,861

1,221,347

1,221,347

Champions Partners

1,791,126

1,791,126

1,583,623

1,583,623

Convening, Capacity Building, Advocacy and other initiatives

5,230,271

5,230,271

World Cancer Congresses

2,947,599

2,947,599

Publications

927,845

Various donations and contributions

359,178

Other

782,909

6,235,986 0

927,845

1,036,677

2,806

361,983

296,914

6,708

303,622

529,152

1,312,061

454,052

12,555

466,607

2,315,503

2,315,503

NCD Alliance

TOTAL INCOME

6,235,986

0

1,036,677

5,140,918

8,709,828

13,850,746

4,592,613

8,570,752

13,163,365

120,692

6,343,073

6,463,766

(242,961)

5,914,276

5,671,316

3,064,370

3,064,370

EXPENDITURE Convening, Capacity Building, Advocacy and other initiatives World Cancer Congresses Operating Costs

4,957,831

4,957,831

NCD Alliance

0 4,897,512

0

4,897,512 2,833,628

2,833,628

5,078,523

9,407,443

14,485,966

4,654,552

8,747,904

13,402,456

62,395

(697,615)

(635,219)

(61,939)

(177,152)

(239,091)

2,472,229

6,589,214

9,061,444

2,456,042

6,766,366

9,222,409

(1,569,784)

(1,569,784)

62,395

(697,615)

(635,219)

(61,939)

(177,152)

(239,091)

Currency exchange fluctuation

(49,037)

0

(49,037)

78,126

0

78,126

FUND BALANCES, end of year

2,485,588

4,321,815

6,807,403

2,472,229

6,589,214

9,061,444

TOTAL EXPENDITURE Revenues over (under) expenditure FUND BALANCES, beginning of year Transfer of NCD Alliance fund balance Revenues over (under) expenditure

2018 UICC Annual Report

42


Board of Directors In October 2018, the General Assembly of UICC took place in Kuala Lumpur and a new Board of Directors was chosen by the full membership of the organisation. Full members had the responsibility to elect a Board of Directors from a slate of 24 talented candidates. The process of forming the slate of 24 candidates is defined in the UICC Constitution and led by the UICC President. A Nominating Committee was formed early in 2018 and included Tezer Kutluk as Immediate Past-President, HRH Princess Dina Mired as President-elect, two Board members not standing for re-election in 2018, Heather Bryant and Gilbert Lenoir, and Sanchia Aranda as President and Chair of the Nominating Committee.

2018 UICC Annual Report

A call for nominations was open from March to May. Over 60 nominations were received for the Board of Directors and two nominations for President-elect. The Nominating Committee met in May to review the nominees, which also included Board members who wished to stand for re-election. The Nominating Committee took into consideration the range of skills, the regions, gender balance and different sectors of membership when developing the final slate of candidates. During the meeting of the General Assembly attended by over 350 delegates, 160 full members elected the new Board of Directors to serve for the period to the next General Assembly in October 2020.

The Board of Directors governs UICC in accordance with the mandate given to it by the General Assembly and it is empowered to provide leadership and strategic direction for all UICC activities. The Board is elected every two years. The Board is composed of 16 outstanding and committed individuals, representing all spectrums of cancer control. All Board members serve in their own personal capacity and not as representatives of their respective organisations or countries. The 2018-2020 Board of Directors is shown on the next page.

43


The 2018-2020 Board of Directors Board Members

President HRH Princess Dina Mired Jordan Wahid AlKharusi Oman

Ana Cristina Pinho Mendes Pereira Brazil

Cristiana Fonseca Portugal

Nick Grant United Kingdom

Anne Lee Hong Kong

Jeff Dunn Australia

Saunthari Somasundaram Malaysia

Ann Steyn South Africa

Ulrika Årehed Kågström Sweden

Danielle Rodin Canada

Alejandro Mohar Mexico

Daiming Fan China

Sally Cowal United States

Zainab Shinkafi-Bagudu Nigeria

President-elect Anil D’Cruz India

2018 UICC Annual Report

44


UICC Geneva team In 2018, our team of 40 highly enthusiastic and talented professionals worked together towards achieving the goals set out in the business plan, under the leadership of Chief Executive Officer, Dr Cary Adams. UICC is proud of having such a fantastic team and appreciate its commitment. It is truly an inspirational team dedicated to make a difference.

Knowledge, Advocacy and Policy Sonali Johnson Shalini Jayasekar-Zurn Yannick Romero Rosie Tasker Zuzanna Tittenbrun

Communications, Marketing and Web Nicole Engelbrecht Charlotte Boulton Patricia Galve Nina Caleffi Scaletscky Thuy Khuc-Bilon Charles Andrew Revkin

Congress and Events

Finance and Administration

Jessica Mathieu Yani Amar Ronan Carella Celine Francina Hugo Nicolaus

Maria Barbara Leon (Chief Operating Officer) Sandrine Fasel Natasha Mehandroo Cindy Ray Philomène Taylor

Capacity Building

Memberships and Partnerships

Kirstie Graham Domenico Iaia Alessandro DiCapua Sally Donaldson Micaela Neumann Marta Pazos Mélanie Samson Rasika Uplekar Sabrina Zucchello

SungAh Lee Muriel Auclaire Lorenzo Boffi Natacha Debbané Laura Fernandez Diaz Julia Knudsen Karine Hentsch

Special Projects Chief Executive Officer Cary Adams

Julie Torode Alexandra Heumber

Chief Operating Officer Maria Barbara Leon

2018 UICC Annual Report

45


Our members

UICC thanks the organisations highlighted in blue that made voluntary contributions above and beyond their statutory membership dues, and those who kindly supported the membership of other members.

2018 UICC Annual Report

46


Our members AFGHANISTAN

Linfomas Argentina

Afghan Society Against Cancer

Sociedad Latinoamericana y del Caribe de Oncología Médica (SLACOM)

National Cancer Control Program Afghanistan

ARMENIA

Broken Hill Prostate Cancer Support Group

Diamond Valley PCSG

Innisfail Prostate Support Group

Bunbury District Prostate Cancer Support Group

Dubbo PCSG

Inverell PCSG

Dural PCSG

Ipswich Prostate Cancer Support Group

Eastern Shore PCSG

Kalamunda PCSG

Eliminate Cancer Initiative - Minderoo Foundation

Kingborough PCSG

Essendon PCSG & Diamond Valley PCSG Far North Queensland (Cairns) PCSG

Kyabram & District Prostate Support Group

Far North Queensland PCSG

Latrobe Valley Prostate Support Group

Forbes Prostate Cancer Support Group

Leederville Prostate Exercise Group

Frankston & District PCSG

Leukaemia Foundation of Australia

Fremantle PCSG

Limestone Coast PCSG

Gawler PCSG

Lockyer Valley PCSG

Gay Melbourne Prostate Cancer Group Gay Prostate Support Adelaide

Lower Eyre Prostate Cancer Support Network

Gay/Bisexual Prostate Cancer Support QLD

Lower North PCSG Ludwig Institute for Cancer Research

Geelong Prostate Support Group

Lymphoma Australia

Geraldton PCSG

Mackay & District Prostate Cancer Support Group

Bundaberg & District Prostate Cancer Support Group

ALGERIA

City of Smile Charitable Foundation

Association d’Aide aux Enfants Cancéreux

National Center of Oncology after V. A. Fanarjyan

Busselton PCA&SG

ARUBA

Cancer Council ACT

Association d’Aide aux Enfants Cancéreux - Béchar Association des Médecins Libéraux d’Annaba Chu Annaba - Clinique Médicale Infantile Sainte El Adwa EL BADR El-AMEL Association ENNOUR for Helping Cancer Patients Sétif Errahma Nassima Nour Doha Sociéte Algerienne de Formation et de Recherche en Oncologie (SAFRO)

Foundation for Promotion of Responsible Parenthood AUSTRALIA Adelaide Hills PCSG Adelaide Mitcham PCSG Albany PCSG Albury Wodonga PCSG Alice Springs PCSG Anastasia Greek Cancer Support Group Ararat & District Prostate Cancer Support Group Armidale PCSG

Cancer Australia Cancer Council Australia Cancer Council Northern Territory Cancer Council NSW Cancer Council Queensland Cancer Council South Australia Cancer Council Tasmania Cancer Council Victoria Cancer Council Western Australia Cancer Nurses Society of Australia Central Australia Support Group Leaders Teleconference Group Central Coast Carers Group Central Coast PCSG

Glass House Country PCSG Glen Innes PCSG

Kingston & Robe PCSG

Mandurah PCSG

Gold Coast North Prostate Cancer Support & Awareness Group

Maryborough Prostate Cancer Support Group Mens Engagement Network

Waha

Australian Catholic University, Exercise Lifestyle Clinic

ANGUILLA

Bairnsdale Prostate & Partners Support Group

Central Gold Coast PCSG

Gold Coast Prostate Cancer Partners Support Group

Melmarsh Prostate Cancer Support Group

Cessnock Prostate Cancer Support Group

Ballarat Prostate Cancer Support Group

Chinese Cancer Society of Victoria Cancer Support Group

Goulburn & District Prostate Cancer Support Group

Monaro Prostate Cancer Support Group

Citiplace Advanced PCSG

Granite Belt PCSG

Clarence Valley Prostate Cancer Support Group

Great Lakes Prostate Cancer Support Group

Movember Foundation Murray Bridge PCSG

Anguilla Family Planning Association

Central Coast Pre Op Support Group

ANTIGUA AND BARBUDA

Barossa Prostate Cancer Support Group

Antigua Planned Parenthood Association Caribbean Family Planning Affiliation, Ltd.

Bass Coast Prostate Cancer Support Group

ARGENTINA

Bayside Kingston PCSG

Clayton Greek Cancer Support Group

Griffith PCSG

Bendigo & Districts Prostate Cancer Support Group

Coffs Harbour PCSG Collie PCSG

Griffith University Menzies Health Institute Queensland

Biloela PCSG

Concord PCSG

Blackwood Districts PCSG

Cootamundra PCSG

Box Hill PCSG Breast Cancer Network Australia

Darwin Prostate Support Awareness Group - Prosper

Brisbane Prostate Cancer Support Network

Devonport PCSG

Asociación Leucemia Mieloide de Argentina (ALMA) Fundación para la Salud del Adolescente Fundación SALES Liga Argentina de Lucha Contra el Cáncer (LALCEC)

2018 UICC Annual Report

Bathurst Prostate Cancer Support Group

Denmark PCSG

Gympie & District PCSG Hastings Prostate Cancer Support Network Hervey Bay Prostate Cancer Support Group Illawarra Prostate Cancer Support Group

Monash University Prostate Cancer Research Group Mudgee Prostate Cancer Support Group Naracoorte Mens Cancer Support Group National Breast Cancer Foundation Nepean/Blue Mountains PCSG Inc. Newcastle/Hunter Mater Prostate Cancer Support Group North Burnett PCSG North Shore PCSG

47


Our members North West QLD Prostate Cancer Support Group Northern Beaches Prostate Cancer Support Group

Prostate Support Group Warrnambool QIMR Berghofer Medical Research Institute

Toowoomba Prostate Cancer Support Group

BANGLADESH

BERMUDA

Townsville PCSG

Aparajita Society of Cancer

Bermuda Cancer and Health Centre

Bangladesh Cancer Society

Teen Services

QLD Advanced PCSG (Telephone Group)

University of Southern Queensland

Northern Rivers Evening PCSG

Queensland and Northern NSW Support Group Leaders Teleconference Group

VCS Foundation

Northern Tablelands PCSG

Redcliffe PCSG

Victoria and Tasmania Support Group Leaders Teleconference Group

Northern Territory Rainbow PCSG

Ringwood PCSG

Victorian Comprehensive Cancer Centre

Ocean Reef PCSG

Riverland PCSG

Wagga Wagga PCSG

Orange PCSG

Rockhampton PCS&A Group

Orbost PCSG

Royal Australian and New Zealand College of Radiologists (RANZCR)

Walter & Eliza Hall Institute of Medical Research

Northern Rivers Day PCSG

Parkes Prostate Awareness and Support Group PCS - City of Onkaparinga Group PCSG Bellarine Peninsula

Royal Prince Alfred Hospital PCSG (Day Group) Royal Prince Alfred Hospital PCSG (Evening Group)

Western Australia Support Group Leaders Teleconference Group Westgate Region Prostate Cancer Support Group

Eminence Obayedullah-Ferdousi Foundation Cancer Hospital and Research Institute (POFF) Oncology Club, Bangladesh BARBADOS The Myeloma, Lymphoma and Leukaemia Foundation of Barbados

BOTSWANA

BELARUS

Nurses Association of Botswana

Belarusian Society of Oncologists

Saddleworth PCSG

Westside Prostate Cancer Support Group

Belgian Foundation against Cancer

Shepparton & District PCSG

Whyalla PCSG

European CanCer Organisation (ECCO)

Shine A Light Group for Gay/Bisexual Men

Wimmera Prostate Cancer Support Group

European Cancer Patient Coalition (ECPC)

Perth PCSG

Shoalhaven PCSG

Wyong PCSG

Perth Southsiders Prostate Cancer Support Group

South Perth PCSG

Yorke Peninsula PCSG

European Organisation for Research and Treatment of Cancer (EORTC)

Southern Highlands PCSG

Younger Men Central Coast PCSG

Perth Western Suburbs Group

St Arnaud PCSG

Younger Men PCSG - Leederville

Port Pirie PCSG

St Vincents PCSG

Prostamates Support Group

St Vincent’s PCSG for Women

Younger Men’s Prostate Cancer Teleconference Group

Prostate (Cancer) Support Awareness Adelaide Group

Stay Strong Prostate Cancer Exercise Group

Prostate Awareness Twin Town & Tweed Coast

Sunraysia Prostate Support Group

Prostate Cancer Action Group (S.A.) Inc.

Sunshine Coast PCSG

AZERBAIJAN

Swan Hill Prostate Support Group

National Oncology Centre of Azerbaijan Republic

Perth Partners Group

Prostate Cancer Foundation of Australia Prostate Cancer Partners SG Bentleigh Bayside Prostate Cancer Support Group ACT Region Prostate Cancer Support Group of Younger Men Prostate Heidelberg Prostate Melbourne Support Group

2018 UICC Annual Report

Sydney Adventist Hospital Educational Presentations (Night) Sydney Adventist Hospital Facilitated Group Discussion (Day)

AUSTRIA Cancer Epigenetics Society

BAHAMAS Bahamas Family Planning Association

Tamworth Prostate Cancer Support Group

BAHRAIN

Taree PCSG

Bahrain Cancer Society

Tatiara Prostate Cancer Support Group Tomaree PCSG

Centro de Investigación, Educación y Servicios (CIES) Fundación Boliviana Contra el Cáncer

BELGIUM

Perth Gay/Bisexual PCSG

Asociación de Lucha Contra la Leucemia Paolo Belli - Instituto de Oncohematología

Barbados Family Planning Association

Westmead PCSG

Peninsula Prostate Cancer Support Group Inc.

BOLIVIA, PLURINATIONAL STATE OF

European Society for Radiotherapy & Oncology (ESTRO) Kom op tegen Kanker Myeloma Patients Europe Patient Organisation Hodgkin and NonHodgkin Diseases

Cancer Association of Botswana

BRAZIL ABRALE Brazilian Lymphoma and Leukaemia Association Américas Amigas Amigos na Luta Contra o Câncer Associação Amor a Vida Associação Brasileira de Apoio aos Pacientes de Câncer (ABRAPAC) Associação Brasileira de Portadores de Câncer AMUCC Associação Brasiliense de Apoio ao Paciente com Câncer - ABAC-Luz Associação Capanemense de Apoio e Prevenção ao Câncer da Mulher - APCM

BELIZE

Associação Cascavel Rosa

Belize Family Life Association

Associação Cearense das Mastectomizadas - Toque de Vida

BENIN Association Franco Béninoise de Lutte Contre le Cancer Association pour la Lutte Contre le Cancer au Bénin Initiative des Jeunes pour le Développement Pathology Laboratory of Faculty of Health Sciences / Cancer Registry of Cotonou Pink Bénin SOS Cancer

Associação das Amigas da Mama- AAMA Associação das Mulheres Iguatuenses Associação de Apoio a Mulher Portadora de Neoplasia - AAMN Associação de Apoio de pessoas com Câncer Associação de Combate ao Câncer da Grande Dourados - ACCGD Associação de Combate ao Câncer do Brasil Central - ACCBC

48


Our members Associação de Mulheres Atuantes de Paraíso do Tocantins - AMAP

Grupo Beltronense de Prevenção ao Câncer

Rede Feminina de Combate ao Câncer de Jaraguá do Sul - RFCC - JS

Associação de Mulheres Mastectomizadas de Brasília

Grupo de Apoio a Criança com Cancer Bahia

Rede Feminina de Combate ao Câncer de Maravilha - R.F.C.C.-Maravilha

Associação do Câncer Amor Próprio Uma Luta pela Vida - AMOR PRÓPRIO

Grupo de Mama Renascer - GRUMARE

Rede Feminina de Combate ao Câncer de Ponta Porã - RFCCPP

Association des Volontaires pour la Santé Familiale

Rede Feminina de Combate ao Câncer de São Bento do Sul

Cameroon Baptist Convention Health Services (CBCHS)

Rede Feminina de Combate ao Câncer de União da Vitória- RFCC - UV

Cameroon Laboratory & Medicine Foundation Health Centre

Rede Feminina de Combate ao Câncer de Xaxim

Solidarité Chimiothérapie - SOCHIMIO

Associação dos Amigos da Mama de Niterói (ADAMA) Associação dos Amigos da Oncologia (AMO) Associação dos Amigos de Prevenção do Câncer- GAMA Associação dos Amigos do CRIO ASSOCRIO Associação em Educação e Saúde da Mama Jesuína Estrela (AMAJES) Associação Feminina de Educação e Combate ao Câncer - AFECC Associação Laço Rosa - pela cura do câncer de mama - Fundação Laço Rosa Associaçao Limeirense de Combate ao Câncer (ALICC) Associação Petropolitana de Pacientes Oncológicos - APPO

Grupo para Motivação e Auto-Ajuda Renovadora - Grupo AMAR Grupo Rosa e Amor Hospital de Caridade de Ijui INCA Instituto Nacional de Câncer Instituto Avon Instituto Brasileiro de Contrôle do Câncer Instituto da Mama do Rio Grande do Sul - IMAMA Instituto de Desenvolvimento e Valorização Humana

Rede Feminina de Combate ao Câncer do Amazonas Rede Feminina de Combate ao Câncer em Alagoas - RFCC Rede Feminina Regional de Combate ao Câncer de Xanxerê - R.F.C.C. - Santa Catarina

CAMBODIA Sihanouk Hospital Center of HOPE

International Society of Nurses in Cancer Care (ISNCC)

CAMEROON

Lymphoma Foundation Canada

Synergies Africaines Contre le Sida et les Souffrances The Michael & Mauritia Patcha Foundation Yaounde Gynaeco-Obstetric and Pediatric Hospital

CAYMAN ISLANDS Cayman Islands Cancer Society CHAD Association DONAMA Association Tchadienne Contre le Cancer

Alberta Health Services - CancerControl

CHILE

Instituto Oncoguia

Association pulmonaire du Québec

Instituto vencer o cancer

BRUNEI DARUSSALAM

Canadian Association of Nurses in Oncology

Canadian Cancer Action Network

Brazilian Oncology Nursing Society

Liga Norteriograndense Contra o Câncer Grupo Despertar

Bulgarian Lymphoma Patients’ Association

Canadian Cancer Society

Brazilian Society of Surgical Oncology (BSSO)

Canadian Federation for Sexual Health

Centro de Integração Amigas da MamaCIAM

Núcleo Assistencial para Pessoas com Câncer - NASPEC

Bulgarian National Association of Oncology (BNAO) Bulgarian Oncology Nursing Society

Elas Por Elas Vozes e Ações das Mulheres

Rede Feminina de Combate ao Câncer de Blumenau - RFCC

Canadian Partnership Against Cancer (CPAC)

LACOG Latin American Cooperative Oncology Group

Rede Feminina de Combate ao Câncer de Brasília (RFCC- DF)

Federación Latinoamericana de Mastología (FLAM)

Rede Feminina de Combate ao Câncer de Brusque - RFCC

Fundação Antonio Prudente - A.C. Camargo Cancer Center

Rede Feminina de Combate ao Câncer de Gaspar

Fundação do Câncer, Brazil

Rede Feminina de Combate ao Câncer de Itajaí - RFCC

2018 UICC Annual Report

The Ottawa Hospital

União e Apoio no Combate ao Câncer de Mama - UNACCAM

BULGARIA

Fundação Maria Carvalho Santos - FMCS

The Cedars Cancer Institute at the McGill University Health Centre

Santa Casa de Misericórdia da Bahia

Instituto Humanista de Desenvolvimento Social - HUMSOL

Liga Mossoroense de Estudos e Combate ao Câncer - Grupo Toque de Mama

Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama (FEMAMA)

Rethink Breast Cancer

Association Tchadienne des Femmes Vivants avec le Cancer

Instituto do Câncer do Ceará - ICC

Canadian Association of Radiation Oncology (CARO - ACRO)

Bem-Estar Familiar no Brasil (BEMFAM)

Princess Margaret Cancer Centre

Alberta Cancer Foundation

Instituto Desiderata

CANADA

Pantai Jerudong Specialist Centre

Associação Rosa Viva - ROSAVIVA

Lymphoma Coalition

BURKINA FASO Action Contre le Cancer Infantile au Burkina Faso Espoir Cancer Féminin Foundation Kimi Solidarité contre le cancer BURUNDI Alliance Burundaise Contre le Cancer (ABCC)

Canadian Institutes of Health Research

Cancer Care Ontario Centre for Chronic Disease Prevention Department of Oncology, Faculty of Medicine, McGill University Direction Générale de Cancérologie, Ministère de la Santé et des Services Sociaux Fondation Québécoise du Cancer International Psycho-Oncology Society (IPOS)

Asociación Chilena de Protección de la Familia Corporación Nacional Maxi-Vida Fundación Arturo López Pérez Fundación Chilena para el Desarrollo de la Oncología - Fundación Cáncer Chile CHINA Cancer Foundation of China China Anti-Cancer Association (CACA) China Cancer Early Diagnosis and Screening Network Chinese Medical Association Fudan University Shanghai Cancer Center Hangzhou Cancer Hospital Henan Anti-Cancer Association Hunan Cancer Hospital Jiangxi Cancer Hospital Liaoning Cancer Hospital & Institute New Sunshine Charity Foundation

49


Our members Oncology Nursing Committee of Chinese Nursing Associations

CONGO DEMOCRATIC REPUBLIC (KINSHASA)

Peking University Cancer Hospital and Institute

CUBA

ECUADOR

FINLAND

Agir Ensemble

Sección Independiente de Control del Cáncer

Asociación Ecuatoriana de Ayuda a Pacientes con cáncer “Esperanza y Vida”

Cancer Society of Finland

Clinique de Pointe à Pitre (CPAP) / Kinshasa

Sociedad Científica Cubana para el Desarrollo de la Familia

Centro Ecuatoriano para la Promoción y Acción de la Mujer

FRANCE

Shanghai Roots & Shoots Sun Yat-sen University Cancer Center

Clinique des Lilas

Fundación Cecilia Rivadeneira

Tianjin Medical University Cancer Institute & Hospital

Ligue Congolaise Contre le Cancer

Sociedad Cubana de Oncología, Radioterapia y Medicina Nuclear

Xinhua Translational Institute for Cancer Pain, Shanghai

Palliafamilli SOCAP

CURAÇAO

Sociedad de Lucha contra el Cáncer (SOLCA)

Alliance des Ligues Francophones Africaines et Méditerranéennes contre le cancer (ALIAM)

COLOMBIA Asociación Pro-Bienestar de la Familia Colombiana Colombian Leukemia and Lymphoma Foundation Funcancer Fundación Esperanza Viva Fundación Red de Apoyo Social de Antioquia (RASA)

COSTA RICA

Foundation for the Promotion of Responsible Parenthood

Asociación Costarricense de Oncólogos Médicos (ACOMED)

CYPRUS

Asociación Demográfica Costarricense

Cyprus Association of Cancer Patients & Friends

Asociación nacional venciendo los obstáculos de la vida (ANASOVI)

Cyprus Anti-Cancer Society

Fundación Jóvenes contra el Cáncer

Association Française des Infirmiers de cancérologie

Alexandria Society for Cancer Patient Care

Association Laurette Fugain

Arab Medical Association Against Cancer (AMAAC)

Cancer Support France

Association d’aide aux Malades du Cancer dans l’Oasis de Dakhla

Cent pour Sang la Vie Paris

CZECH REPUBLIC

Association Médicale Franco-Egyptienne

League Against Cancer Prague

Can Survive Egypt

Asociación Tour Rosa de Costa Rica

Lymfom Help

Egyptian Society for Promotion Of Women’s Health

DENMARK

Alliance Mondiale Contre le Cancer

EGYPT

Asociacion Profesional del Enfermeras Oncohematologicas Fundación Dra. Anna Gabriela Ross

AFROCANCER

Cancérologues Sans Frontières Centre Antoine Lacassagne Centre Eugène Marquis Centre Georges-François Leclerc Centre Henri Becquerel

CÔTE D’IVOIRE

Danish Cancer Society

Fakkous Center for Cancer and Allied Diseases

Centre Léon Bérard

Instituto de Cancerología S.A. Instituto Nacional de Cancerología Colombia

Aidons les Personnes Atteintes ou Affectées par le Cancer

LYLE – Patientforeningen for Lymfekræft & Leukæmi

Medical Research Institute

Centre Paul Strauss

La Asociacion de Enfermeria Oncologica Colombiana

Association de Soins Palliatifs de Côte d’Ivoire

National Cancer Institute - Cairo

Centre Régional François Baclesse

DJIBOUTI

Liga Colombiana Contra el Cáncer

Association Imagine le Monde

Registro Poblacional de Cáncer de Cali de la Universidad del Valle

Association Ivoirienne de Lutte Contre le Cancer

Fundación SIMMON

COMOROS Union Comorienne Contre le Cancer

DOMINICA

Association Ivoirienne des Soins Palliatifs

Dominica Cancer Society

Fundación Edificando Vidas, El Salvador

Hope Life

Dominica Planned Parenthood Association

Ligue Ivoirienne Contre le Cancer Société Ivoirienne de Pathologie (SIPath)

Accompagnez la vie

SOS Cancers

Fondation Calissa Ikama Fondation Globeathon Congo Brazzaville Union Congolaise contre le Cancer

2018 UICC Annual Report

Asociación Demográfica Salvadoreña Asociación Salvadoreña para la Prevención del Cáncer

CONGO (BRAZZAVILLE) Association des Infirmiers du Congo Bénévoles pour le Bien être Familial

Association pour le Développement du Millénaire

EL SALVADOR

Centre Régional Jean Perrin Expertise France Fondation ARC pour la Recherche sur le Cancer Fondation JDB-prévention cancer France Lymphome Espoir

ESTONIA

French League Against Cancer

DOMINICAN REPUBLIC

Estonian Cancer Society

Asociación Dominicana Pro-Bienestar de la Familia

ETHIOPIA

Groupe Franco-Africain d’Oncologie Pédiatrique

CROATIA

Liga Dominicana Contra el Cáncer

Association of Patients with Leukemia and Lymphoma

Patronato Cibaeño Contra el Cáncer

Croatian League Against Cancer

Centre Oscar Lambret

Un Paso Max

Mathiwos Wondu Ye-Ethiopia Cancer Society

Gustave Roussy Gynécologie Sans Frontières Institut Bergonié

FIJI

Institut Curie

Fiji Cancer Society

Institut de Cancérologie de Lorraine

Fiji Islands Ministry of Health and Medical Services

Institut de Cancérologie de l’Ouest Institut du Cancer de Montpellier

50


Our members Institut Jean Godinot Institut National du Cancer (INCA)

Ghana Health Service, Non Communicable Disease Control Program

Institut Paoli Calmettes

Mctonne Cancer Care Foundation

Institut pour la Prévention de Cancer du Sein

GREECE

Institut Universitaire du Cancer Toulouse Oncopole NESSMA OncoMali Pathologie Cythologie et Développement Physicien Médical Sans Frontières Raid Evasion Run

Hellenic Cancer Society Hellenic Society of Medical Oncology (HeSMO)

Ligue Gabonaise Contre le Cancer

GUATEMALA

GEORGIA

Asociación de Pacientes con LMC -ASOPALEU-

GERMANY Deutsche Krebsgesellschaft e.v. - DKG Deutsche Krebshilfe

Asociación Guatemalteca Héroes de Esperanza Asociación Pro-Bienestar de la Familia de Guatemala Instancia por la salud y el desarrollo de las Mujeres ISDM Liga Nacional Contra el Cáncer Guatemala One Voice Against Cancer GUINEA

Deutsche Leukaemie & Lymphom-Hilfe eV

Génération Sans Tabac

Deutsches Krebsforschungszentrum (DKFZ)

GUYANA

Krebsallianz GmbH GHANA

Delhi State Cancer Institute

HONDURAS

Dharamshila Cancer Hospital and Research Centre

Asociación Hondureña de Planificación de Familia

Association Guadeloupeenne pour le Planning Familial

Tbilisi State Medical University

Innovating Health International

GRENADA

GABON

Research Institute of Clinical Medicine (Todua Clinic)

Centre of Excellence for Oncology (Nayati Healthcare)

Asociación Hondureña de Lucha contra el Cáncer

GUADELOUPE

National Cancer Center of Georgia

Catholic Medical Mission Board (CMMB)

International Institute of Anticancer Research

UNICANCER

Georgian Nursing Association

Cancer Society of Madhya Pradesh

Asociación de Pacientes con Cáncer Fe Y Esperanza

Grenada Planned Parenthood Association

Georgia Patient Union

Cancer Patients Aid Association

Association pour la Promotion de la Famille Haitienne

Hellenic Society of Oncology

SOS Don de Moelle Osseuse Moyen Orient

Fondation Sylvia Bongo Ondimba (FSBO)

HAITI

Guyana Cancer Prevention Society Guyana Responsible Parenthood Association

DM Wayanad Institute of Medical Sciences Dr. Bhubaneswar Borooah Cancer Institute Enhance head neck rehabilitation & enhance social initiative Friends of Max

Liga Contra el Cáncer - Honduras

Global Marwari Charitable Foundation

HONG KONG

Healis Sekhsaria Institute For Public Health

Asian Fund for Cancer Research

Gujarat Cancer & Research Institute

Global Chinese Breast Cancer Organizations Alliance

HealthCare Global Entreprises

Hong Kong Anti-Cancer Society

Institute Rotary Cancer Hospital (IRCH)

Hong Kong Blood Cancer Foundation (HKBCF) Maggie Keswick Jencks Cancer Caring Centre Foundation Ltd. World Cancer Research Fund Hong Kong (WCRF HK) HUNGARY Hungarian League Against Cancer ICELAND Icelandic Cancer Society INDIA All India Institute of Medical Sciences (AIIMS) Apollo Cancer Institute, Apollo Hospitals Hyderabad

African Cancer Organisation

CanCare Foundation

Breast Care International (BCI)

Cancer Aid & Research Foundation

Cancer Society of Ghana

Cancer Foundation of India

Indian Cancer Society - National HQ

Regional Cancer Centre, Thiruvanathapuram Ruby Hall Clinic Saroj Gupta Cancer Centre & Research Institute Sri Venkateswara Dental College and Hospital Sterling Addlife India Private Limited Swasthya Jagriti Sansthan Tagore Dental College and Hospital, Chennai, India. Tata Memorial Hospital The Oncology Nurses Association of India Tibetan Cancer Society V Care Foundation INDONESIA Indonesia CML & GIST Community, ELGEKA

Kidwai Memorial Institute of Oncology

Indonesian Breast Cancer Foundation / Yayasan Kanker Payudara Indonesia

Life Again Foundation

Indonesian Cancer Foundation

Mahatma Gandhi Cancer Hospital & Research Institute

Indonesian Cancer Information and Support Center Association (CISC)

Malabar Institute of Medical Sciences College of Nursing ( MIMS College of Nursing)

Indonesian Center for Expertise in Retinoblastoma (ICER)

Max Healthcare Meherbai Tata Memorial Hospital

Indonesian Radiation Oncology Society (IROS)

National Institute of Cancer Prevention and Research (NICPR)

National Cancer Control Committee (NCCC)

No Tobacco Association

Rumah Sakit Kanker Dharmais - National Cancer Center

North East Cancer Hospital and Research Institute

Indonesian Oncology Nurses Association

Piramal Swasthya Management and Research Institute Post Graduate Institute of Medical Education and Research Rajiv Gandhi Cancer Institute & Research Centre

Cancer Institute (WIA)

2018 UICC Annual Report

51


Our members IRAN, ISLAMIC REPUBLIC OF

European School of Oncology

National Cancer Research Center - Japan

KOREA, REPUBLIC OF

LUXEMBOURG

Behnam Daheshpour Charity Organization

Fondazione “Edo Ed Elvo Tempia Valenta” Onlus

Niigata Cancer Center

Korean Cancer Association

Een Häerz fir Kriibskrank Kanner

Fondazione IRCCS “Istituto Nazionale dei Tumori”

Osaka International Cancer Institute

The Fondatioun Kriibskrank Kanner

Princess Takamatsu Cancer Research Fund

Korean Society for Radiation Oncology (KOSRO)

Cancer Institute, Imam Khomeini Medical Center KASSA - the society to support children suffering from cancer MAHAK “Society to Support Children Suffering from Cancer”

Instituto Nazionale Tumori Regina Elena Patologi oltre Frontiera

Saga-ken Medical Centre Koseikan Saitama Cancer Center Sapporo Cancer Seminar Foundation

Korean Society of Medical Oncology (KSMO) National Cancer Center - Korea Yonsei Cancer Center

MACEDONIA, REPUBLIC OF Borka – For Each New Day MADAGASCAR Fondation Akbaraly

Noor Cancer Charity (NCC)

Soleterre-Strategie di Pace Onlus

Reza Radiotherapy and Oncology Center

UPMC San Pietro

IRAQ

JAMAICA

Tochigi Cancer Center

Kurdistan Save the Children

Jamaica Family Planning Association

Tokyo Metropolitan Komagome Hospital

Kosova Task Force for Cancer Control (KTCC)

JAPAN

JORDAN

IRELAND

Aichi Cancer Center

King Hussein Cancer Center

KUWAIT

Irish Cancer Society

Asia Cancer Forum

King Hussein Cancer Foundation

Kuwait Society for Preventing Smoking and Cancer (KSSCP)

MALAYSIA

Lymphoma Support Ireland

Cancer Solution K.K.

National Cancer Control Programme

Chiba Cancer Center

KAZAKHSTAN

KYRGYZSTAN

Cancer Research Malaysia

UPMC Whitfield Cancer Centre

Foundation for Promotion of Cancer Research

Almaty Oncology Centre

Public Foundation “Ergene”

KanWork Cancer Society

Zhianawa Cancer Center

ISRAEL Flute of Light Hadassah

Group Nexus Japan Higashi Sapporo Hospital

Sasaki Foundation Shizuoka Cancer Center

Kazakh Research Institute of Oncology/ Radiology (Kazior) Together Against Cancer Kazakhstan

Hokkaido Cancer Society

KENYA

Japan Cancer Society

Aga Khan University Hospital

Japan Lung Cancer Society

Amref Health Africa

Associazione Italiana contro le Leucemielinfomi e mieloma – Pazienti

Japan Society of Clinical Oncology

Childhood Cancer Initiative

Japan Society of Gynecologic Oncology

Eddah’s Hope Cancer Foundation

Associazione Italiana di Oncologia Medica (AIOM)

Japanese Breast Cancer Society

Faraja Cancer Support Trust

Associazione Italiana Malati di Cancro Parenti e Amici (AIMAC)

Japanese Cancer Association (JCA)

Henzo Kenya

Japanese Foundation for Cancer Research (JFCR)

Kenya Cancer Association (KENCANSA)

Israel Cancer Association ITALY

Associazione Italiana per la Ricerca sul Cancro Associazione Vittorio Tison Cultura e Solidarietà Centro di Riferimento Oncologico Centro di Riferimento per l’Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO)

2018 UICC Annual Report

Japanese Foundation for Multidisciplinary Cancer Treatment Jikei University School of Medicine Kanagawa Cancer Center Kyushu Cancer Center Mie University Hospital Miyagi Cancer Center

Kenya Hospices and Palliative Care Association (KEHPCA) Kenya Network of Cancer Organizations National Cancer Institute of Kenya National Nurses Association of Kenya PECA-Kenya Women 4 Cancer Early Detection & Treatment

Zero Club KOSOVO

LAO PEOPLE’S DEMOCRATIC REPUBLIC

Union Malagasy Contre le Cancer MALAWI Malawi Cancer Registry Women Coalition Against Cancer in Malawi - WOCACA

Breast Cancer Welfare Association

Malaysian Oncological Society Max Family Society Malaysia

Laos Oncology Unit

National Cancer Council (MAKNA)

LATVIA

Pink Ribbon Wellness (L) Foundation

August Kirchenstein Institute of Microbiology & Virology Limfomas Pacientu Atbalsta LEBANON Children’s Cancer Center of Lebanon (CCCL) Lebanese Cancer Society

National Cancer Society of Malaysia Prostate Cancer Society Malaysia University of Malaya, Faculty of Medicine MALDIVES Cancer Society of Maldives MALI

Naef K. Basile Cancer Institute

Association de Lutte contre le Tabac, l’Alcool et les Stupéfiants

LITHUANIA

Association de Lutte Contre les Maladies Cancéreuses (ALMAC)

Kraujas National Cancer Institute - Lithuania

Simasoh-Nani International MALTA Action for Breast Cancer Foundation

52


Our members MARTINIQUE Association Martiniquaise pour l’information et l’orientation Familiales MAURITANIA Association Mauritanienne de lutte contre le cancer Association pour la Santé Préventive de la Femme Association pour Mieux Vivre avec le Cancer Gynécologique Ligue Mauritanienne de Lutte Contre le Cancer Ministère de la Santé - Programme national de lutte contre le Tabagisme de Mauritanie MAURITIUS Breast Cancer Care Leukaemia Foundation Link to Life MEXICO Asociación Gerardo Alfaro A.C. Asociación Mexicana contra el Cancer de Mama AC “Fundación Cima” Asociación Mexicana De Leucemia y Gist A.C. Asociación Mexicana de Lucha Contra el Cáncer A.C. Asociación Mexicana de Sobrevivientes al Cáncer Oncoayuda A. C. Casa de la Amistad para Niños con Cancer I.A.P

Instituto Nacional de Cancerología México Mexican Association of Mastology

NAMIBIA

NIGER

Sebeccly Cancer Care and Support Centre

Cancer Association of Namibia

Association Against Leukemia in Niger Centre National de Lutte contre le Cancer

Society of Oncology and Cancer Research of Nigeria

Ministry of public health of the Republic of Niger

The Bricon Foundation The Dorcas Cancer Foundation

Société Nigérienne de Cancérologie

Tobacco Control Foundation of Nigeria. (Nigeria Tobacco Control Alliance)

Nuevo Patronato del Instituto Nacional de Cancerología, A.C.

NEPAL

Salvati AC

Cancer Society Nepal

Sociedad Mexicana de Oncología, AC (SMeO)

Children’s Cancer Foundation

Sociedad Mexicana de Radioterapeutas AC Tómatelo a Pecho, A.C. Unidos... Asociación Pro trasplante de médula ósea. Francisco Casares Cortina A.C. MONGOLIA Mongolian Oncology Nursing Society National Cancer Council of Mongolia MOROCCO AMAL (Association des malades atteints de leucémies) Association de Soutien des Cancéreux de l’Oriental Association SOS Face Marrakech Hôpital Cheikh Khalifa Ibn Zaid

B.P. Koirala Memorial Cancer Hospital

Nepal Cancer Hospital and Research Center Nepal Cancer Relief Society (NCRS) Nepal Cancer Support Group

Act of Random Kindness Foundation International (ARKFI)

Childhood Cancer International (CCI) Dutch Cancer Society Erasmus MC Cancer Institute European Waldenström Macroglobulinemia Network (EWMnetwork) IKNL Integraal Kankercentrum Nederland International Kidney Cancer Coalition (IKCC) LymfklierkankerVereniging Nederland

Access to Basic medical Care Foundation.

Breast Cancer Association of Nigeria (BRECAN) CancerAware Nigeria Care Organisation Public Enlightenment (COPE)

University of Abuja Nigeria University of Nigeria Teaching Hospital Cancer Support Group (UNTH CSG) West African College of Surgeons (WACS) NORWAY Aktiv mot kreft Norwegian Cancer Society OMAN National Oncology Centre, the Royal Hospital, Muscat Oman Cancer Association

David Omenukor Foundation

PAKISTAN

Ego Bekee Cancer Foundation

Cancer Patients’ Welfare Society (CPSW) NIMRA

Foundation for Carcinoma of the Prostate Transatlantic Leah Cancer Centre

Green Hills Science College Muzaffarabad, Kashmir Pakistan

Lalla Salma Foundation - Cancer Prevention and Treatment

Wereld Kanker Onderzoek Fonds (WCRF NL)

Université Mohammed VI des sciences de la santé

NEW ZEALAND

mass medical mission

Cancer Society of New Zealand Inc.

Medicaid Cancer Foundation

MOZAMBIQUE

Leukaemia & Blood Cancer New Zealand

Nigerian Cancer Society

PALESTINE, STATE OF

Beira Cancer Registry

University of Otago

Nursing and Midwifery Council of Nigeria

Alhayat Association for Cancer Control

Partnership for Eradication of Cancer in Africa - PECA Nigeria

Augusta Victoria Hospital

Project PINK BLUE - Health & Psychological Trust Centre

Patient’s Friend’s Society-Jerusalem

COI Centro Oncológico Internacional

CBL Medical Center Myanmar Oncology Society

Asociación Pro-Bienestar de la Familia Nicaraguense

2018 UICC Annual Report

Tous Unis Contre le Cancer

NETHERLANDS (THE)

NICARAGUA

Grupo de Recuperación Total Reto A.C.

TATALLI

NIGERIA

MYANMAR

Fundacion Nacional de Pacientes con Linfoma no Hodgkin (FunaLinH)

SOS Tabagisme

Tulasi Maya Memorial Cancer Relief Foundation

Centro de Investigación de Cancer en Sonora (CICS) Fundación Mexicana para la Planeación Familiar, A.C.

SOS Cancer Niger

Pinlon Hospital Shwe Yaung Hnin Si Cancer Foundation U Hla Tun Hospice (Cancer) Foundation

Fundación Alas de Vida Fundación Movimiento Contra el Cáncer (Movicancer-Nicaragua)

Lifetouch Africa (reg. as Life Touch For African Women Health Initiative)

Pakistan Atomic Energy Commission (PAEC) Shaukat Khanum Memorial Cancer Hospital & Research Centre

Palestinian Oncology Society

Raise Foundation Minna Run For a Cure Africa Breast Cancer Foundation Save a Life Cancer Awareness and Support Network

53


Our members PANAMA

PHILIPPINES

RUSSIAN FEDERATION

Asociación Nacional Contra el Cáncer

Benavides Cancer Institute, University of Santo Tomas Hospital

Equal Right to Life

Asociación Panameña para el Planeamiento de la Familia Panamanian Oncology Nursing Society PAPUA NEW GUINEA Papua New Guinea Cancer Foundation Papua New Guinea National Cancer Centre PARAGUAY Centro Paraguayo de Estudios de Población Fundacion Unidos Contra El Cancer FUNCA Paraguay Haematooncology Pediatric Department, Faculty of Medical Sciences, National University of Asunción Sanatorio San Roque PERU ALIADA Asociación Peruana Vidas Sin Cáncer ESPERANTRA Fundación Peruana de Cáncer Instituto de Oncología & Radioterapia de la Clínica Ricardo Palma Instituto Nacional de Enfermedades Neoplásicas (INEN) Instituto Peruano de Paternidad Responsable Liga Peruana de Lucha contra el cáncer Luz de Esperanza Oncosalud S.A.C. Sociedad Peruana De Enferenonas Encologas

Cancer Warriors Foundation, Inc I Can Serve Foundation Kythe Foundation Inc. Philippine Alliance of Patients’ Organisations Philippine Cancer Society Philippine Children’s Medical Center Philippine Oncology Nurses Association Inc. St. Luke’s Medical Center - Quezon City The Cancer Institute Foundation, Inc.

Zahra Breast Cancer Association

SOUTH AFRICA African Cancer Institute, Stellenbosch University

SENEGAL

Society for Assistance to People with Oncohematologic Disease

Hôpital Aristide Le Dantec, CHU Dakar

African Organisation for Research & Training in Cancer (AORTIC)

The Association for Directors, Institutes of Oncology and Radiology, CIS&Eurasia (ADIOR)

Institut pour la Formation et la Recherche en Urologie et en Santé de la Famille

Campaigning for Cancer Cancer Association of South Africa

Ligue Sénégalaise Contre le Cancer

The National Society of Pediatric Hematologists and Oncologists

Ministry of National Education Senegal - Division du Controle Medical Scolaire (DCMS)

Cape Peninsula University of Technology, Faculty of Health & Wellness Sciences

RWANDA

Association Cancer du Sein du Sénégal

SERBIA Kosovo Association of Oncology - KAO

POLAND

Inshuti Mu Buzima (Partners In Health Rwanda)

LIPA Lymphoma Patient Association

International Hereditary Cancer Center

Rwanda Children’s Cancer Relief

Polish Lymphoma Association

Rwanda Palliative Care and Hospice Organisation

Oncology Nursing Section, Nurses Association of Serbia

PORTUGAL

Slovensko Združenje Bolnikov z Limfomom in Levkemijo, L&L

N.N. Petrov National Medical Research Center of Oncology

Butaro Hospital

Touched By Max

Serbian Society for the Fight Against Cancer

National Oncology Nursing Society of South Africa People Living with Cancer (PLWC) PinkDrive WiA - Women in Action SPAIN AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia Asociación Española Contra el Cáncer

AEOP - Portuguese Association Oncology Nurse

SAINT KITTS AND NEVIS Nevis Family Planning Association

SIERRA LEONE

Associacao Portuguesa Contra a Leucemia (APCL)

St. Kitts Family Life Services Association Ltd.

Crusaders Club Ministry Sierra Leone MEPS Trust Well Woman Clinic

Assoçiacão Portuguesa de Leucemias e Linfomas (APLL)

SAINT LUCIA

SINGAPORE

Institut Catala d’Oncologia

Champalimaud Foundation

St. Lucia Planned Parenthood Association

Leukemia & Lymphoma Foundation

Société Internationale de Sénologie - SIS

Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE

SAINT VINCENT AND THE GRENADINES

National Cancer Center - Singapore

Vall Hebron Institut of Oncology (VHIO)

Liga Portuguesa Contra o Cancro PUERTO RICO Asociación Puertorriqueña Pro-Bienestar de la Familia QATAR Qatar Cancer Society ROMANIA Association P.A.V.E.L. Romanian Nursing Association (RNA)

2018 UICC Annual Report

N.N. Blokhin Russian Cancer Research Center

Sheikh Mohammed Hussien Al-Amoudi Center of Excellence in Breast Cancer (SMHA-CEBC)

Singapore Cancer Society

St. Vincent Planned Parenthood Association

The Skin Cancer Institute

SAMOA

Lymfoma Slovakia

Samoa Cancer Society Inc.

Slovak League Against Cancer

SAUDI ARABIA

SLOVENIA

King Abdullah Medical City / Oncology Center

Društvo Bolnikov z Limfomom

Ministry of Health - Saudi Arabia

Slovenian Coalition for Public Health, Environment and Tobacco Control

Saudi Cancer Society

SLOVAKIA

Federación Española de Cancer de Mama - FECMA Fundación CRIS Contra el Cáncer Fundación Theodora

SRI LANKA Sri Lanka Cancer Society SUDAN Khartoum Oncology Specialized Center The Radiation & Isotopes Centre Khartoum (RICK)

Ljubljana Institute of Oncology

54


Our members SURINAME

TANZANIA, UNITED REPUBLIC OF

TURKEY

Stichting Lobi

Medical Women Association of Tanzania

SWEDEN Blodcancerförbundet

Ministry of Health Community Development, Gender, Elderly and Children of Tanzania

Fondation des Enfants Atteints de la Leucémie

Cancer Society in Stockholm

Ocean Road Cancer Institute

Swedish Cancer Society Cancerfonden

T-MARC Tanzania

SWITZERLAND

THAILAND

CANSEARCH Foundation European Society for Medical Oncology (ESMO) Fondation ISREC GAVI Vaccine Alliance Ho/Noho - Schweizerische Patientenorganisation für Lymphombetroffene und Angehörige HUG - Hôpitaux Universitaires de Genève International Society for Geriatric Oncology (SIOG) SIOP International Society of Pediatric Oncology

Tumaini La Maisha Tanzania

Department of Pediatrics, Faculty of Medicine, Prince of Songkhla University MaxSmiles National Cancer Institute - Thailand

Macmillan Cancer Support

KÖKDER

Public Health England

Ministry of Health - Turkey

Velindre NHS Trust

Turkish Association for Cancer Research and Control (TACRC)

World Cancer Research Fund (WCRF UK)

International Planned Parenthood Federation Western Hemisphere Region

World Cancer Research Fund International (WCRF)

International Waldenstrom’s Macroglobulinemia Foundation (IWMF)

Turkish Oncology Nursing Society Turkish Society for Radiation Oncology Turkish Society of Lung Cancer Turkish Society of Medical Oncology

UGANDA

TOGO

Global Colon Cancer Association

Global Cancer Institute

Istanbul University Oncology Institute

Thai Pediatric Oncology Group

Alola Foundation

Leukaemia CARE Lymphoma Association

Urooncology Society in Turkey

TIMOR-LESTE

Fred Hutchinson Cancer Research Center

Help Those With Cancer Association

Thai International Chemotherapy Society The Wishing Well Foundation

King’s Health Partners Comprehensive Cancer Centre

African Palliative Care Association Bless a Child Foundation Uganda Cancer Institute Uganda Cancer Society Uganda Women’s Cancer Support Organization (UWOCASO)

UNITED STATES Abramson Cancer Center, University of Pennsylvania

Global Oncology Indiana University Simon Cancer Center International Cancer Expert Corps (ICEC)

Jhpiego Corporation Leukemia & Lymphoma Society Love Hope Strength Foundation

American Association for Cancer Education

Lymphoma Research Foundation

American Association for Cancer Research - AACR

Missouri Cancer Registry & Research Center, University of Missouri School of Medicine Dept. of Health Management & Informatics

American Cancer Society American Childhood Cancer Organization American College of Surgeons American Institute for Cancer Research

Memorial Sloan Kettering Cancer Center

National Cancer Institute - USA National Comprehensive Cancer Network

SWISS BRIDGE Foundation

Association pour la Promotion de la Santé et du Bien-Etre Social (APSBES)

Swiss Cancer League

Ligue Togolaise Contre le Cancer

SYRIAN ARAB REPUBLIC

TRINIDAD AND TOBAGO

Ukrainian Public Association for Patients with Chronic Lymphoproliferative Diseases

Association Médicale Franco-Syrienne

Family Planning Association of Trinidad and Tobago

American Society of Clinical Oncology (ASCO)

Partners HealthCare

UNITED ARAB EMIRATES Burjeel Medical City - VPS HealthCare LLC

Basic Health International, Inc

Patients Against Lymphoma (PAL)

Dubai Healthcare City

Campaign for Tobacco-Free Kids

Friends of Cancer Patients

CancerCare

Perlmutter Cancer Center, NYU Langone Health

Mediclinic City Hospital FZ-LLC

Centers for Disease Control and Prevention (CDC)

Pink Ribbon Red Ribbon Prevent Cancer Foundation

Chicago Blood and Cancer Foundation

Reach to Recovery International

College of American Pathologists

RTI International

Cutaneous Lymphoma Foundation

Society of Gynecologic Oncology (SGO)

Dana Farber Cancer Institute

Society of Surgical Oncology

Direct Relief

St. Baldrick’s Foundation

ECHO Institute at the University of New Mexico

St. Jude Children’s Research Hospital

TAIWAN, PROVINCE OF CHINA Formosa Cancer Foundation

TUNISIA

Hope Foundation for Cancer Care

Association des Malades du Cancer

TAJIKISTAN

Association Tunisienne Contre le Cancer

NGO AVESTO Tajikistan

Association SELIMA Association Tunisienne d’Assistance aux Malades du Cancer du Sein

Positive Cancer Foundation UNITED KINGDOM

Association Tunisienne de Soins Palliatifs - Gabès

Breast Cancer Now

Association Tunisienne des SagesFemmes

Cancer52

Association Tunisienne des Soins Palliatifs

2018 UICC Annual Report

UKRAINE

Cancer Research UK ecancer

American Society for Clinical Pathology (ASCP) American Society for Radiation Oncology (ASTRO)

National Foundation for Cancer Research North American Association of Central Cancer Registries Oncology Nursing Society PATH

55


Our members Susan G. Komen for the Cure T-Cell Leukemia Lymphoma Foundation The Eye Cancer Foundation The George Washington University Cancer Institute The Max Foundation The Ohio State University Comprehensive Cancer Center The University of Texas MD Anderson Cancer Center

VENEZUELA, BOLIVARIAN REPUBLIC OF Asociación Civil de Planificación Familiar Asociación de Ayuda a Pacientes HematoOncologicos “ASAPHE” Asociación Venezolana de Amigos con Linfoma Fundación Hemato-Oncológica Guyana (Fundahog) Sociedad Anticancerosa de Venezuela

UCSF Helen Diller Family Comprehensive Cancer Center

Venezuelan Breast Cancer Research and Education Foundation

University of Colorado Cancer Center

VIET NAM

University of Hawaii Cancer Center University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center University of Miami - Sylvester Comprehensive Cancer Center University of Pennsylvania UPMC UW Carbone Cancer Center Young Professionals Chronic Disease Network

Breast Cancer Society of Hue Ho Chi Minh City Oncological Hospital Supportive Fund For Cancer Patients Bright Future Vietnam Cancer Society VIRGIN ISLANDS, BRITISH BVI Family Life Association VIRGIN ISLANDS, U.S. Virgin Islands Family Planning Association

URUGUAY

YEMEN

Asociación Uruguaya de Planificación Familiar (AUPF)

National Cancer Control Foundation

Comisión Honoraria de Lucha contra el Cáncer

UICC uses ISO 3166-1 as a reference to name countries. ISO 3166-1 is part of the ISO 3166 standard published by the International Organization for Standardization (ISO), and defines codes for the names of countries, dependent territories, and special areas of geographical interest.

ZAMBIA Breakthrough Cancer Trust

Fundación Porsaleu

Cancer Diseases Hospital

Grupo Linfoma Uruguay

Tobacco - Free Association of Zambia Zambian Cancer Society ZIMBABWE Cancer Association of Zimbabwe - Harare Branch Cancerserve Trust Hospice & Palliative Care Association of Zimbabwe Zimbabwe National Cancer Registry

2018 UICC Annual Report

56


Our partners

UICC thanks its portfolio of dedicated partners, without whom the organisation could not carry out its work.

2018 UICC Annual Report

57


Our partners VANGUARDS BENEFACTORS PARTNERS 2018 UICC Annual Report

58


Partners’ support per programme

World Cancer Congress

Tata Trusts

World Cancer Day

Fondation Philanthropia

Amgen

American Cancer Society

Boehringer Ingelheim

Amgen

Bristol-Myers Squibb

American Society for Clinical Oncology (ASCO)

MSD

American Society for Clinical Oncology (ASCO)

Roche

Cancer Society of Finland

Bayer

Pfizer

Patient Groups Programme

Fellowships

AbbVie

Astellas

Advocacy

Capacity Building

Convening

American Cancer Society

Danish Cancer Society Israel Cancer Association

Roche

Young Leaders Programme Roche

American Cancer Society

Bristol-Myers Squibb

World Cancer

Prevent Cancer Foundation

Centers for Disease Control and Prevention

Canadian Partnership Against Cancer

Leaders’ Summit

Swiss Cancer League

American Cancer Society

UICC-Japan Committee

Bristol-Myers Squibb

National Cancer Institute USA Susan G. Komen Swiss Cancer League Tata Trusts World Cancer Research Fund International

Member support

Cancer Council Australia

American Cancer Society

Cancer Research UK

Astellas

China Anti-Cancer Association

Canadian Partnership Against Cancer

Merck Group

Merck Group

MSD

MSD

National Cancer Institute USA

National Cancer Institute USA

Novartis

Pfizer

Oman Cancer Association

Roche

Pfizer

Susan G. Komen

Bristol-Myers Squibb

French Cancer League

Prevent Cancer Foundation

Canadian Partnership Against Cancer

Israel Cancer Association

Roche

Novartis

Tata Trusts

Swedish Cancer Society

UICC-Japan Committee

Swiss Cancer League

Varian

Tata Trusts

World Cancer Research Fund International

Cancer Council Australia Cancer Research UK Cancer Society of Finland Danish Cancer Society DKG (German Cancer Society) The Economist Events

2018 UICC Annual Report

UICC-Japan Committee Unicancer

Swedish Cancer Society

Master Courses

Pfizer

CEO Programme

Prevent Cancer Foundation Roche

MSD Prevent Cancer Foundation

Grants

Treatment for All Susan G. Komen

Pfizer

Supporting new initiatives City Cancer Challenge Access Acelerated Amgen American Society for Clinical Oncology (ASCO)

American Society for Clinical Pathology

Roche

Direct Relief

UPMC

Elekta Icon Group

Sanofi Espoir Foundation Varian

59


Thank you

Union for International Cancer Control

uicc.org

31 – 33 Avenue Giuseppe Motta 1202 Geneva, Switzerland T +41 (0)22 809 1811 F +41 (0)22 809 1810 E info@uicc.org

@uicc

Profile for UICC

UICC 2018 Annual Report  

2018 was a great year for UICC, working with the global community across our key areas of focus: convening, capacity building, advocacy and...

UICC 2018 Annual Report  

2018 was a great year for UICC, working with the global community across our key areas of focus: convening, capacity building, advocacy and...

Profile for uicc.org